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Bacterial receiver domain proteins modulate the intracellular response to external stimuli
in two-component systems. There is a new subclass of receiver domains associated with
Histidine Tryptophan Glutamate kinases (HWE-kinases) that have divergent sequence
properties. The enzyme Sma0114 is a receiver domain that is a substrate for an HWEkinase. The structure and dynamics of the Sma0114 protein were explored using nuclear
magnetic resonance (NMR). Differences between the NMR structures of the inactive and
activated states occur in helix α1, the active site loop that connects strand β3 and helix
α3, and in the 455 (α4-β5-α5) face. In most receiver domains, the 455 face undergoes a
structural rearrangement in the activated state to make it competent for binding
downstream target molecules. Coupling between the 455 face and the active site
phosphate is mediated through the rearrangement of a threonine and tyrosine residue via
a mechanism called Y-T coupling. The NMR structure indicates that Sma0114 lacks Y-T
coupling, and that communication between the active site and the 455 face is achieved
through a conserved lysine residue that stabilizes the acyl phosphate in receiver domains.
15

N-NMR relaxation experiments reveal a loss of entropy due to binding ligands at the

active site with compensating entropic increases in the 455 face. The dynamic character
of the 455 face in Sma0114, which in part results from replacement of helix α4 by a
flexible loop, may facilitate induced-fit binding of target molecules.
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Chapter One. Introduction
Two-component systems mediate signal transduction in bacteria
Bacterial signal transduction is commonly accomplished using two-component
systems that allow bacteria to sense changes in their environment and respond using
highly sophisticated phosphorylation relays (1, 2). The archetypal two-component
system utilizes a histidine kinase that autophosphorylates itself in response to external
stimuli and a response regulator that undergoes structural reorganization in response to
phosphoryl transfer from its cognate histidine kinase (1). The histidine kinase component
has two domains, an N-terminal external domain that senses environmental changes and
an autokinase domain that autophosphorylates at a histidine residue. The response
regulator component is located in the cytoplasm and also typically has two domains, a
receiver domain that is phosphorylated by its cognate histidine kinase and an effector
domain that carries out an output response that usually involves DNA binding to affect
gene transcription. Receiver domains have a conserved α5/β5 Rossmann fold, where 5 αhelices surround 5 parallel β-sheets whereas effector domains vary among response
regulators according to their downstream function.

Receiver domains have a conserved structure in response regulator proteins
Receiver domains have several conserved sequence motifs: (I) a pair of acidic
residues in the β1/α1 loop (Lβ1/α1) that coordinate a divalent metal cation, (II) an aspartate
at the C-terminal end of strand β3 that serves as the phosphorylation site, (III) a threonine
at the C-terminal end of strand β4 that hydrogen bonds with the phosphate moiety via its
sidechain hydroxyl group, (IV) an aromatic (tyrosine or phenylalanine) in strand β5 that
1

rotates its aromatic ring toward the hyrdophobic core upon reorientation of the threonine
sidechain and (V) a lysine that flips its sidechain toward the phosphate group to provide a
stabilizing salt bridge upon phosphorylation. The conserved features are highlighted on
the ribbon diagram of sporulation factor Spo0F, a receiver domain from Bacillus subtilis
in Figure 1-1. The role of the receiver domain is to accept a phosphate from its cognate
histidine kinase forming a high-energy phospho-Asp bond that triggers the activation of
the enzyme (1, 3). As such, the receiver domain acts as a “switch” that undergoes a
conformational change in response to phosphorylation (1, 2). The effector domain
typically mediates the downstream output response that is often DNA binding to affect
gene expression (1, 2).
A smaller subset of about 15% of response regulators are single domain proteins,
containing only the receiver domain (4-6). Of the ~30,000 non-redundant receiver
domain sequences known, ~200 have been structurally characterized (4). Some single
domain proteins housing only a receiver domain include CheY and Spo0F (1, 7, 8). The
roles of single domain response regulators are not as well understood as their two-domain
counterparts but there are three known functions. The receiver domain can act directly on
a protein effector such as in the case of CheY, it can participate in a phospho-relay
cascade as in the case with Spo0F, or it can act as a histidine kinase inhibitor as in the
case with DivK (5, 9, 10). Structural studies of receiver domains have shown that these
are structurally similar in their inactive apo forms but show greater variability in their
phosphorylated activated states (11). This is likely because the function of the inactive
receiver domain is to receive a phosphate from its cognate histidine kinase, whereas the
activated enzyme can bind to a wide range of downstream effector proteins (12, 13).
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Figure 1-1 Structure of the receiver domain Spo0F. The α/β topology consists of a fivestranded parallel β-sheet surrounded by five α-helices. Conserved features of the active
site are highlighed in red (I) metal binding site, in green (II) the phosphorylation site, in
pink (III) the Thr of Y-T coupling, in purple (IV) the aromatic Phe of Y-T coupling and
in blue (V) the Lys that forms a salt bridge with the phosphate. PDB codes 1NAT and
1PUX correspond to the inactive and activated structures respectively.
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Activation of Receiver Domains
Activation of receiver domains is accomplished by phosphorylation at a
conserved aspartate in the presence of a divalent metal ion such as Mg2+, Mn2+, or Ca2+
(14). A conserved pair of acidic residues located in the loop between strand β1 and helix
α1, form part of the binding site for a divalent metal cation which is required for
stabilizing the incoming phosphate group and forming the acyl-phosphate linkage (2, 4).
The site of phosphorylation is a conserved Asp at the C-terminal end of strand β3 (1, 2).
The C-terminal end of strand β5 houses a conserved Lys that stabilizes the incoming
phosphate group (4). Upon phosphorylation, receiver domains undergo a conformational
transition to an activated state, becoming primed for binding the downstream effector
molecules that elicit the signal transduction output response. Receiver domains have
autophosphatase enzymatic activity that controls the lifetime of the activated state, and
hence the duration of the output response (15, 16).
In typical receiver domains, the phosphorylation state of the active site is
communicated to the output 455 (α4-β5-α5) face of the enzyme that typically forms a
binding surface for downstream targets. Activation of the protein is relayed to the 455
face through a conformational rearrangement called 'Y-T coupling', involving a
structurally conserved tyrosine (Y) and threonine (T) (1). In this mechanism a Thr in
strand β4 forms a hydrogen bond with the phosphate via its sidechain hydroxyl group.
The cavity left by the Thr sidechain reorientation is filled by the reorientation of an
aromatic sidechain (Tyr/Phe) from a residue in strand β5 (Figure 1-1). Upon activation
the enzyme undergoes a structural rearrangement commonly in the 455 face. The receiver
domain is then primed to carry out the output response.

4

Sma0114 deviates from known receiver domain enzymes
The two-component system encoded by the genes sma0113 and sma0114 from
the bacterium Sinorhizobium meliloti, was identified in a genetic screen for altered
succinate-mediated catabolite repression (17). S. meliloti is a gram-negative soil
bacterium in the α-proteobacteria. The bacterium can exist in the soil as a free-living
organism, or it can live as a nitrogen-fixing symbiont in specialized organs called
nodules, that it induces on the roots of certain legumes such as alfalfa. Based on previous
work it is expected that sma0113 and sma0114 play a role in S. meliloti catabolite
repression and polyhydroxy butyrate synthesis (17). The tandem genes encode a
histidine-tryptophan-glutamate (HWE) histidine kinase (Sma0113), and a single-domain
response regulator (Sma0114).
The architecture of the classic histidine kinase involves two modular domains
termed the dimerization and catalytic domains. The dimerization domain is a helix bundle
and the catalytic domain has a mixed α/β topology with five β-strands and three αhelices. In archetypal histidine kinases the H box that houses the conserved His for
autophosphorylation is located in the dimerization domain (1). The catalytic domain is
responsible for ATP binding and contains several conserved sequence motifs. The N, G1,
G2 and F boxes are amino acid motifs involved in nucleotide binding (1, 2).
HWE-kinases were first described in 2004 (18) and constitute a subclass of the
larger histidine kinase superfamily. Compared to the well-characterized histidine kinase
family, HWE-kinases have an altered ATP binding site, which lacks the F box that is
normally an integral component of the ATP lid. There is a His in what appears to be the
H box of the HWE-kinase, however, there is little alignment between this H box and
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known H box sequences. Furthermore, there is a His in the N box as well as Trp and Glu
residues in the G1 box of the protein (18). The His, Trp and Glu resides in the H and G1
boxes are essential for autophosphorylation of the HWE-kinase family.
Preliminary sequence analysis of Sma0114 reveals that it adopts a prototypical
Rossmann-fold but has features that set it apart from other receiver domains. Sma0114
has many conserved residues typically present in receiver domains including the Asp
(Asp60) that accepts a phosphate from its cognate HWE-kinase Sma0113 and a pair of
acidic residues involved in prototypical metal binding (Glu15 and Asp16). One
interesting feature of Sma0114 is the presence of a new motif PFxFATGY located in the
beta strand that houses the Thr typically involved in the classic Y-T coupling mechanism.
Although the conserved Thr is present in the sequence, Sma0114 does not have the
conserved aromatic residue that is the other half of this coupling motif.
The NMR investigations described herein show that the unusual sequence features
of Sma0114 lead to unique structural features, primarily affecting the 455 face of the
enzyme. 15N relaxation data show that there are also changes in the dynamics of the 455
face of Sma0114 compared to the corresponding regions of other receiver domains (19,
20). By contrast the active site of the enzyme and the ability to bind metals is retained,
suggesting that the unusual features of Sma0114 do not alter the activation mechanism
but rather the conformational changes of the 455 face accompanying phosphorylation.

6

Chapter 2. Chemical Shift Assignments for Sma0114
Abstract
Response regulators of bacterial two-component systems undergo extensive
structural reorganization in response to phosphoryl transfer from their cognate histidine
kinases. The response regulator encoded by the gene sma0114 of S. meliloti is a part of a
unique class of two-component systems that employ HWE histidine kinases. The distinct
features of Sma0114 include a PFxFATGY motif that houses the conserved threonine in
the “Y-T coupling” conformational switch and the replacement of the conserved Phe/Tyr
in Y-T coupling by a Leu. Presented here are 1H, 15N, and 13C NMR assignments for
Sma0114. Chemical shift assignments are a pre-requisite for an NMR study. Secondary
structural elements of the protein were identified based on TALOS chemical shift
analysis, 3JHNHa coupling constants and hydrogen-deuterium exchange. The secondary
structure determined by NMR is in good agreement with that predicted from the
sequence.

7

Introduction
Receiver domains of response regulators are typically about 110 amino acids
long and are structurally and functionally analogous to members of the Ras family of
small eukaryotic GTPases (21). It was expected that the 120 amino acid (13.5 kDa)
Sma0114 protein would have a CheY-like structure, belonging to the α/β Rossmann-fold
superfamily. Regulatory regions of Sma0114 were identified via comparison to known
receiver domains and include a set of conserved residues clustered in an active site at the
C-terminal edge of the β-sheet. Two additional conserved amino acids include a
hydroxylic residue (Ser/Thr) and an aromatic residue (Phe/Tyr) that play direct roles in
communication between the active site and output response α4-β5-α5 (455) face of the
protein. The Y-T coupling mechanism thus transforms the overall character of the 455
face of the protein. The conformational transition in turn governs the specific
interactions that mediate the output response (22-24).
Sma0114 is a member of a recently identified class of response regulators
associated with HWE-kinases. Response regulators associated with the HWE kinases
(25) either because the two components are linked on the same polypeptide chain or
encoded in the same operon like the Sma0113(histidine kinase)/114 (response
regulator)pair, often have a conserved motif at the C-terminal end of strand β4. Response
regulators containing this PFxFATGY, or “FAT GUY” motif have not been structurally
characterized. To better understand the unique features of Sma0114 including the nonconserved Y-T coupling mechanism, the role of the PFxFATGY motif, and activation by
its cognate HWE kinase an NMR characterization of the structure and dynamics of the
protein was undertaken.
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Results
Backbone Chemical Shift Assignments
A series of NMR experiments were used to obtain chemical shift assignments for
the enzyme. Several through-bond (TOCSY-type) experiments were used initially to
establish backbone resonance assignments in Sma0114. Specifically, two redundant
sequential walk pathways were used. Using multiple pathways ensured the accuracy of
the resonance assignments. The first pathway used Cα connections via HNCA and
HN(CO)CA experiments. The second pathway used backbone carbonyl connections via
HNCO and HN(CA)CO experiments. HNCACB experiments were used in conjunction
with the Cα and carbonyl sequential walk methods. The HNCACB experiment was used
to correlate the Cα and Cβ resonances of a single residue using through-bond coupling to
the Cα and Cβ of the preceding residue in the sequence. Using this method, full chemical
shift assignments were obtained. Figure 2-1 illustrates example resonances from the
HNCACB spectrum of the inactive enzyme. Using these multidimensional NMR
experiments backbone amide resonances were assigned in a 2D 1H-15N HSQC of
Sma0114. The 2D 1H-15N HSQC spectrum is unique to a polypeptide chain and provided
a platform with which to characterize other atomic assignments. The 1H-15N HSQC
experiment is the most ubiquitously used spectrum to identify a protein and is often used
to establish amino acids involved in substrate binding. Backbone 1H-15N assignments for
apo-Sma0114 are summarized in Figure 2-2.
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Figure 2-1 HNCACB Spectra for the sequence Arg78-Glu77-Ala76-Leu75-Ile74.
Greater intensity Cα and Cβ peaks in each panel correspond to the residue X. Lower
intensity Cα and Cβ resonances belong to the residue X-1 in the amino acid sequence.
For example, the R78 panel contains contours corresponding to the Cα and Cβ chemical
shifts for Arg78 as well as lower intensity Cα and Cβ resonances belonging to Glu77. In
this sequential walk manner 1H and 15N as well as Cα and Cβ chemical shifts were
determined. Dotted green lines in each panel identify the spin systems. Blue and red
resonances represent Cα and Cβ peaks respectively.

10

Sidechain Chemical Shift Assignments
Sidechain resonances were also assigned using 3D through-bond correlation
(TOCSY) experiments. Manual assignments using HCCH-TOCSY experiments,
described by Kay, L.E. et al. were employed first, however, the lower resolution of the
experiments made unambiguous assignments difficult and tedious. For example,
resolving methyl group 1H resonances to unique residues was particularly challenging. In
order to make unambiguous assignments for aliphatic sidechain 13C and 1H resonances
we used the approach described by Sun, Z.Y. et al (26). The described 3D HCCONH and
CCONH experiments correlate aliphatic proton and carbon resonances with the HN
group of each residue in the sequence. The HN correlation provides the unambiguous
avenue for sidechain assignments as each amino acid has one unique HN chemical shift
(Figure 2-2). Sidechain chemical shifts were necessary to provide comprehensive
assignments for the enzyme to be used in through-space or NOESY-type experiments.
Unambiguous assignments helped improve the precision of the NMR structure of the
enzyme.

11

Figure 2-2 1H-15N HSQC spectrum of Sma0114. Backbone assignments are indicated
with pink labels. Peaks that could only be seen at contours lower than shown (M4, E17)
are denoted by squares. Side chains amide resonances are indicated with blue dashed
lines and labels, with the superscript SC. Data were collected at pH 6.0 and a
temperature of 37°C.
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Secondary Structure of Sma0114
Following chemical shift assignments for backbone and sidechain residues,
secondary structure predictions were performed using PSIPRED (27). These data are
summarized in Figure 2-3. The secondary structure established by NMR agrees with the
secondary structure predicted from the sequence using the PSIPRED server (27). Both
methods indicated that helix α4 of the prototypical CheY-fold, was absent in Sma0114
(corresponding to residues 90-99). The 455 face of response regulators is critical in
transmitting the kinase phosphorylation signal to downstream binding partners (24, 28),
so the absence of helix α4 in Sma114 led to the conclusion that there was a new distinct
mechanism of coupling between HWE kinases and their cognate response regulators.

13

Figure 2-3 Secondary structure of Sma0114. (A) Amino acid sequence of Sma0114,
amide protons protected from exchange after 2 hour in D2O at pH 6.0 and 37 oC, TALOS
predictions of secondary structure based on HN, N, Hα, Cα, Cβ and C’ chemical shifts
(29), and secondary structure predicted using the PSIPRED server (27). (B) Cα chemical
shifts minus random coil values (30). Positive deviations correspond to α-helix, negative
to β-sheet. (C) Cβ chemical shifts minus random coil values (30). Negative deviations
correspond to α-helix, positive to β-sheet. (D) 3JHNHα couplings obtained from a 3D
HNHA experiment, presented as 3JHNHα – 7 Hz. Positive and negative differences
correspond to β-sheet and α-helix secondary structure, respectively.
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Reprinted from Sheftic et al. 2012 (31)
I performed all experiments except the secondary structure prediction Figure 3-5

Chapter Three. NMR Structure and Dynamics of Apo-Sma0114

Abstract
The solution NMR structure and dynamics of Sma0114 from the bacterium S.
meliloti is described. This is the first such characterization of a receiver domain from the
HWE-kinase family of two-component systems. The structure of Sma0114 adopts a
Rossmann-fold but has features that set it apart from other receiver domains. Sma0114
lacks the fourth α-helix of the consensus 455 face and 15N relaxation data show that it is
replaced by a segment that is flexible on the ps-ns timescale. Secondary structure
prediction of Sma0114 and other HWE-kinase-associated receiver domains suggests that
the absence of helix α4 may be a conserved property of this family. In spite of these
differences, Sma0114 has a conserved active site, binds divalent metal ions such as Mg2+
and Ca2+ that are required for phosphorylation, and exhibits µs-ms active site dynamics
similar to other receiver domains.

15

Introduction
In order to correlate the new sequence features of Sma0114 with changes in
tertiary structure we solved the solution NMR structure of the enzyme. Presented here is
the 3-dimensional structure of Sma0114 in the apo state. The NMR data support the
secondary structure predictions presented in Chapter 2 and prove that the topology of the
protein deviates from an α5/β5 fold to an α4/β5 fold. The missing α-helix maps to the area
of the protein that based on sequence alignments would house helix α4, the first
constituent of the 455 face.
15

N T1, T2, and NOE relaxation data were used as input for a Model-Free

simulation that provides information on the amplitude (S2 order parameter) and timescale
of bond motions (32). Dynamics data are compared between the inactive and activated
protein (Chapter 4) to assess the role of flexibility in enzyme function. Dynamics of the
apo-protein reveal that the loop replacing helix α4 between strands β4 and β5 is flexible
on the ps-ns timescale, indicative of fast motions similar to those seen for protein N and
C-termini. Analysis of µs-ms dynamics reveal four distinct regions of the protein that
have increased R2ex terms, indicative of conformational exchange.
We performed a metal titration in order to determine saturating concentrations of
a divalent cation required to stabilize the acyl-phosphate linkage in the active site of
Sma0114. Our initial profile of chemical shift changes in 1H-15N HSQC spectra upon
Mg2+ binding showed a weak affinity for the metal ion. The unusually high (150 mM)
concentration of MgCl2 required to saturate the metal binding site led to a loss in
signal/noise during data acquisition presumably due to the increase in salt concentration
within the sample. In order to circumvent the use of high metal concentrations, CaCl2 was
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titrated into Sma0114 samples in order to determine the affinity of the enzyme for Ca2+.
A concentration of 1.5 mM CaCl2 was required to saturate the metal binding site
indicating preferential binding of Ca2+ for Sma0114.
The NMR investigations described herein show that the unusual sequence features
of Sma0114 lead to unusual structural features, primarily affecting the 455 face of the
enzyme. 15N relaxation data show that there are also changes in the dynamics of the 455
face of Sma0114 compared to the corresponding regions of other receiver domains (19,
20). By contrast the active site of the enzyme and the ability to bind metals is retained.
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Results
Solution NMR Structure of Apo-Sma0114
Structure statistics for the NMR models calculated are given in Table 3-1. Figure
3-1 shows the NMR structure of Sma0114. The overall fold of the protein is similar to the
canonical α5/β5 Rossman-fold of other receiver domains, which is schematically
illustrated in Figure 3-1A. Backbone (Cα, N, C') traces of the 20 lowest energy NMR
structures of Sma0114 are shown in Figure 3-1B.
The NMR structure of Sma0114 closest to the ensemble average is compared with
that of a typical receiver domain Spo0F in Figures 2C and 2D, respectively. The
deviations from the canonical receiver domain fold occur primarily along the 455 face of
Sma0114. The most conspicuous difference in Sma0114 (Figure 3-1C), is that helix α4 is
replaced by a disordered segment (residues 88-93). Another difference, is that strand β5
which is shorter than the other β-strands due to two flanking proline residues (P101,
P106), turns inward toward the core of the Sma0114 structure (Figure 3-1C).
To look more closely for similarities and differences to other receiver domains,
the DALI server (33) was used to find the 10 best structural matches to Sma0114. The 10
best matches were all structures of inactive states of receiver domains, and had an
average backbone RMSD of 3.17 Å to our Sma0114 structure over an average alignment
length of 99 residues. The most prominent difference in Sma0114 is the absence of helix
α4 (Figure 3-1C). Another important change is that the loop following strand β3 appears
to cover and possibly restrict access to the phosphorylation site residue, Asp60 (Figure 31C), whereas it extends away from the hydrophobic core in the homologous structures
(Figure 3-1D).
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Table 3-1: Statistics for the 20 Lowest Energy NMR Structures of Sma0114
NMR restraints (total)

1627

Distance (total)

1431

Intraresidue NOEs

422

Sequential NOEs

486

Short range NOEs (1< |i-j| < 5)

109

Long range NOEs (5 < |i-j|)

414

Hydrogen bonds (32x2)

64

Dihedral (ϕ 61, ψ 54, χ1 17)

132

Residual restraint violations
NOE (Å)1

0.039 ± 0.004

Dihedral (°)2

0.539 ± 0.018

RMS deviations from ideal geometry
Bonds (Å)

0.0040 ± 0.0003

Angles (°)

0.73 ± 0.02

Improper torsions (°)

0.54 ± 0.02

Van der Waals energy (kcal/mol)3

86.28 ± 2.37

Lennard-Jones energy (kcal/mol) 4

-83.18 ± 7.40

ProcheckNMR Z-score5

-2.52

Ramachandran plot
most favored (%)

82.3

allowed (%)

15.3

generously allowed (%)

1.8

disallowed (%)

0.6

Coordinate RMS deviations (Å)
NMR ensemble to average

Cα, C, N

All Heavy

Entire domain (110 residues)

0.94

1.46

Excluding loops (72 residues)7

0.86

1.38

6

_________________________________________________________________________
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1

Structure contains no NOE violations greater than 0.3Å
Structure contains no dihedral violations greater than 5°
3
Evdw was calculated using the X-PLOR Frepel function (34) with van der Waals interactions and
atomic radii set to 0.8 times their CHARMM (35) values.
4
EL-J was calculated using the CHARMM empirical energy function (35)
5
ProcheckNMR used via Protein Structure Validation Suite (PSVS) (36)
6
Excluding N-terminus (residues 1-9) and C-terminus (residues 118-123)
7
Only residues in regular secondary structure (10-15, 19-31, 34-39, 42-51, 56-60, 70-78, 81-86,
102-105, 108-117)
2
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The alignment to structurally homologous proteins using the DALI server (33) also
indicates that the C-terminal portion of the PFxFATGY motif in Sma0114 differs from
the corresponding region in the canonical receiver domain fold. The PFxFATGY motif is
highlighted in cyan on the NMR structure of Sma0114 in Figure 3-2A. This motif
encompasses all of strand β4 and forms the beginning of the loop between strands β4 and
β5. The conserved Thr86 of the Y-T coupling pathway is part of this motif and is the last
residue in strand β4 (shown in purple in Figure 3-2A). The partner aromatic residue in the
Y-T coupling mechanism is replaced by a Leu103 in strand β5 (shown in black in Figure
3-2A). The absence of the conserved aromatic residue has also been seen in the single
domain response regulator CheY2 from S. meliloti, an enzyme that has been reported to
lack Y-T coupling (37). These changes provide compelling evidence that the
prototypical Y-T coupling mechanism is altered in Sma0114.
The two residues of the PFxFATGY motif that form part of the loop immediately
following strand β4 (Gly87 and Tyr88) show large structural differences in Sma0114
compared to the top 10 structural similarity hits. These two residues are located
immediately before the start of the disordered segment that replaces helix α4 in Sma0114.
The C-terminal portion of the PFxFATGY motif in Sma0114 superimposes with the Nterminal portion of helix α4 in the 10 closest structural matches. Together with the
placement of the Y-T coupling threonine, this suggests that at least the C-terminal part of
the PFxFATGY motif belongs to the 455 face of Sma0114.
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Figure 3-1 Fold and NMR structure of Sma0114. (A) Topology diagram for the
canonical α5/β5 Rossman fold of receiver domains. Parallel β-sheets (blue) are
surrounded by α-helices (green) with pink segments indicating loops. The fourth α-helix
which is disordered in Sma0114 is also indicated in pink. (B) Backbone representation of
the 20 lowest energy NMR structures. Regular secondary structure elements 9-15 (β1),
19-31 (α1), 34-39 (β2), 42-51 (α2), 55-60 (β3), 70-78 (α3), 81-86 (β4), 102-105 (β5),
110-117 (α5) were used to superimpose the structures. (C) NMR structure of Sma0114
closest to the ensemble average. The fourth α-helix is replaced by a disordered segment.
(D) NMR structure of Spo0F (PDB accession code 1NAT) (38). The fourth α-helix is
shown in pink. N and C termini are noted in (C) and (D) with N and C respectively.
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Figure 3-2 Active site of Sma0114. (A) Stereo-diagram of the NMR structure of
Sma0114 closest to the ensemble average, showing selected sidechains of active site
residues: metal-ligands Glu15 and Asp16 in red, the phosphorylation site Asp60 in green,
and Thr86 and Leu103 of the Y-T coupling pair in purple and pink, respectively. The
PFxFATGY motif is shown in cyan. (B) Stereo-view of the 20 lowest energy NMR
structures of Sma0114 illustrating the precision of sidechains from different parts of the
molecule. Sidechains comprising the hydrophobic core (blue) are well defined while
those of active-site residues (color scheme as above) show poorer precision due to
increased dynamics on the µs-ms timescale.
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While the 455 face of the enzyme shows deviations from the receiver domain
superfamily, the active site of Sma0114 has features consistent with other receiver
domains (Figure 3-2A). The metal binding residues, Glu15 and Asp16, are located at a
conserved position in the loop between β1 and α1 (11, 13, 39). The phosphorylation site
(Asp60) is at the C-terminal end of β3 like in other receiver domains. The hydroxylic
residue (Thr86) that hydrogen bonds with the incoming phosphate in the Y-T coupling
mechanism is located at the C-terminal end of strand β4. The basic residue Lys105,
which typically stabilizes the activated state by forming a salt bridge with the incoming
phosphate occurs in a conserved location in strand β5.
Strands β1-β4 and helices α1-α3 have the highest precision in the NMR structure
(Figure 3-2B). Regions with lower precision occur in the 455 face and include the
segments corresponding to helix α4, strand β5, and helix α5. The active site of Sma0114
also has lower precision in the NMR structure, as illustrated in Figure 3-2B which
compares sidechains of residues in the active site and in the hydrophobic core of the
protein. The equilibrium shift theory of activation hypothesizes that receiver domains
exist in their inactive and active substates simultaneously in solution. Activation via
phosphorylation shifts the population from the inactive to the active form (4, 20). It
follows that that the active site, which is experiencing exchange between inactive and
active conformational substates on a µs-ms timescale, would have a lower precision due
to R2ex line broadening. To verify that the lower precision of the active site and 455 face
in the NMR structure of Sma0114 is due to genuine flexibility, as it is in other receiver
domains (39, 40), we characterized the backbone dynamics of the protein using 15N
relaxation data.
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NMR Relaxation Data Show Increased Flexibility for the 455 Face and Active Site
Relaxation data for Sma0114 are shown in Figure 3-3. The R1 values are
roughly constant over the length of the protein with a mean value of 2.00 ± 0.01 s-1,
except for raised rates in the region between residues 89 and 99, which also shows
lowered 1H-15N NOEs (Figure 3-3A). The R2 data reveal four distinct regions that have
relaxation contributions greater than the mean value of 8.0 ± 0.3 s-1, as indicated in
Figure 5B. The mean 1H-15N NOE value is 0.75 ± 0.01, close to the theoretical maximum
of 0.80 (41). Lowered 1H-15N NOEs are seen for the chain termini and the region
between residues 88 and 95 that corresponds to the missing helix α4 (Figure 3-3C).
To interpret the relaxation data in terms of backbone dynamics we performed a
Model-Free analysis (42) using the program Tensor2 (Figure 3-4). We obtained a
correlation time of 5.1 ns for Sma0114, consistent with a monomeric protein of 13.5
KDa. The S2 values which describe the amplitudes of internal motions on the ps-ns
timescale are shown in Figure 3-4A and are mapped on the NMR structure in Figure 34B. Except for the chain termini, the only region in the protein with low S2 order
parameters is the flexible segment that replaces helix α4 (Figure 3-4A). The R2ex terms
that describe exchange contributions to R2 relaxation from dynamics on the µs-ms
timescale are shown in Figure 3-4C and are mapped on the NMR structure in Figure 34D. Residues that experience significant R2ex contributions cluster to four region of the
protein: (I) the metal binding site, (II) the phosphorylation site, (III) Thr86 which is
predicted to hydrogen bond with an incoming phosphate in the Y-T coupling mechanism,
and (IV) Lys105 which stabilizes the incoming phosphate through a salt-bridge. Thus all
four regions with R2ex contributions are in the active site of the enzyme, which has been
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shown for other receiver domains to be subject to µs-ms timescale interconversion
between inactive and active substates as described in the equilibrium shift theory of
activation (19, 20).
Despite their strong structural homology, receiver domains from various twocomponent systems exhibit different dynamics on the µs-ms timescale. R2ex terms for
Spo0F, an intermediate in the sporulation relay of B. subtilis, are larger for the metal
binding site compared to the 455 face of the enzyme (19). Conversely, in NtrC, the
nitrogen regulatory response regulator from S. typhimurium, R2ex contributions are large
for the 455 face of the enzyme whereas the metal binding site shows no exchange
broadening (6, 20). The R2ex profile of Sma0114 differs from Spo0F and NtrC in that it
shows exchange broadening not only in the metal-binding and phosphorylation sites but
also in the β5 and α5 regions of the conserved 455 face.
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Figure 3-3 15N NMR relaxation data for Sma0114. (A) R1 rates. (B) R2 rates. (C) 1H15

N NOE values. Error bars are shown for all data points but in some cases are smaller

than the symbols used to depict the data. The secondary structure of Sma0114 is
indicated with arrows (β-sheets) and cylinders (α-helices) in each panel.
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Figure 3-4 Model-free analysis of Sma0114. (A) S2 order parameters. (B) S2 order
parameters mapped onto the NMR structure of Sma0114. The color map goes from blue
(rigid) to red (flexible). (C) R2ex values. (D) R2ex values mapped onto the NMR structure
of Sma0114 with colors ranging from blue (negligible R2ex contributions) to red (large
R2ex contributions). Residues for which no data were available are shown in black.
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The Family of Receiver Domains Associated with HWE-Kinases is Predicted to Lack
Helix α4
The NMR structure of Sma0114 is the first of an HWE-kinase associated receiver
domain. Due to the unusual features of this enzyme we performed a bioinformatics
analysis to determine if the absence of helix α4 is a conserved property of this subfamily.
The structure prediction program PsiPred (43) was used to evaluate the secondary
structure of 84 receiver domains with cognate HWE-kinase partners. Of the 84 proteins
considered, 71 were predicted to lack helix α4 (Figure 3-5A). A subset of 13 HWEassociated receiver domains are predicted to have helix α4 but then appear to lack the last
helix α5 (Figure 3-5B). This suggests that most of the HWE-associated receiver domains
in which helix α4 is present, have compensatory perturbations that disrupt helix α5 of the
455 face. By contrast, all of the α-helices and β-strands of the consensus Rossman fold
are accurately predicted by the PsiPred program for a control group of 8 receiver domains
of known structure that are not associated with HWE-kinases (Figure 3-5C).

Sma0114 Binds Mg2+ and Ca2+
We next wanted to see if divalent cations, which are required for the stabilization
of the acyl-phosphate linkage (4, 14), are able to bind to Sma0114 in spite of the
differences seen for the 455 face. Several groups have used Mg2+ to study the metalbound states of receiver domains (11, 13, 44). In the case of Sma0114 we found that
Mg2+ binds very weakly, with a Kd near 75 mM and saturation at 150 mM Mg2+. The
MgCl2 concentration required to stabilize the fully metal bound state leads to a decrease
in sensitivity for NMR experiments due to high solution ionic strength, especially for data
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Figure 3-5 Secondary structure prediction of 84 HWE-associated receiver domains. Each
row corresponds to one receiver domain. (A) Subset of 71 receiver domains with cognate
HWE-kinases, all of which are predicted to be missing helix α4. Sma0114 is at the top of
the figure labeled with an arrow. (B) Subset of 13 HWE-associated receiver domains
predicted to have helix α4. Note that most of the members of this subset are predicted to
be missing the alternate helix α5 of the 455 face. (C) Control group of 8 receiver domains
of known α5/β5 structures used to verify the secondary structure prediction algorithm.
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collection with a cryogenic probe. An additional problem is that the large Mg2+
concentration needed to saturate Sma0114 causes non-specific binding to clusters of
acidic residues in the protein. Finally, Sma0114 is more susceptible to aggregation on the
timescale of days to weeks needed for a detailed NMR characterization, in the presence
of high (> 100 mM) concentrations of MgCl2.
Due to the problems associated with Mg2+, we carried out an NMR titration using
CaCl2 as an alternative metal. Superimposed 1H-15N spectra of apo and Ca2+-bound
Sma0114 are shown in Figure 3-6A. In contrast to Mg2+ which has a Kd of 75 mM
(Figure 3-6B), Sma0114 binds Ca2+ with a ~1 mM Kd, and saturation is achieved at 1.5
mM concentrations of CaCl2 (Figure 3-6C). Residues that show the greatest chemical
shift changes upon addition of Ca2+ are indicated with boxes in Figure 3-6A, and for the
most part cluster to the active site.
Figure 3-7 shows the chemical shift perturbations observed in 1H-15N HSQC
spectra of Sma0114 due to addition of CaCl2 (Figure 3-7A) and MgCl2 (Figure 3-7B).
The unusually large concentration of MgCl2 necessary to achieve saturation induces nonspecific binding to acidic Asp and Glu residues as illustrated by the large number of the
chemical shift perturbations and line broadening effects observed (Figure 3-7B). By
contrast, with CaCl2 perturbations are mostly restricted to the active site of the enzyme
(Figure 3-7A). Some residues become broadened rather than experiencing chemical shift
changes upon addition of CaCl2 or MgCl2, and these are indicated with arrows in Figure
3-7. They include Glu17, which is one of the ligands for Ca2+, and Lys105, which is part
of the active site. Although most studies of metal-bound receiver domains have used
Mg2+, Ca2+ was used for structural studies of Spo0A and PhoP (45, 46).
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Figure 3-6 Metal-binding of Sma0114 followed by NMR spectroscopy. (A)
Superposition of 1H-15N-HSQC spectra for the apo (black) and Ca2+-bound forms of
Sma0114 (pink). Active site residues that show the largest chemical shift perturbations
and are indicated with green boxes. Titration curves for residues as a function of
increasing MgCl2 (B) or CaCl2 (C) concentrations. Please note the different scaling of the
x-axis in (B) and (C). Errors in chemical shift differences estimated from the digital
resolution of the spectra were 0.02 ppm for (B) and (C).
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Figure 3-7 Perturbations of Sma0114 1H-15N resonances due to metal-binding. Bar
graphs show composite HN and N chemical shift changes (ΔHN + 0.1(ΔN)) that occur in
the presence of 1.5 mM CaCl2 (A) or 150 mM MgCl2 (B). Residues in boxes indicate
amino acids that experience large chemical shift perturbations upon metal binding.
Arrows represent residues that broaden beyond detection in the presence of the metals.
Errors in the composite chemical shift changes estimated from the digital resolution of
the spectra were 0.03 ppm.
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Discussion
Several groups have characterized the inactive and active conformations of
receiver domains (11, 39, 44). Understanding the structural features of these enzymes
has provided a wealth of insight into their functions. The Sma0114 receiver domain,
which may be prototypical of receiver domains associated with HWE-kinases, has a
conserved active site but shows substantial differences in the 455 face, which is used to
propagate signal transduction intracellularly.
The structural and dynamic differences in the 455 face of Sma0114 suggest that
this enzyme has an altered recognition interface for binding to downstream effectors. The
PFxFATGY motif that is specific to receiver domains associated with HWE-kinases,
forms strand β4 in the Sma0114 structure (Pro81-Thr86) and the rigid part of the
following loop (Gly87 and Tyr88). The last residue in the PFxFATGY motif demarcates
the start of the Tyr88-Leu93 segment, which replaces helix α4 in Sma0114, and shows
low S2 order parameters consistent with a dynamically disordered region. The only other
receiver domain for which S2 order parameters have been described is the inactive form
of Spo0F (19). In the case of Spo0F, it was shown that except for the chain termini, the
protein is rigid on the ps-ns timescale. In typical receiver domains, helix α4 is a key
element of the 455 face that undergoes concerted structural rearrangements following
phosphorylation to form a new binding surface for downstream effector proteins (11, 40).
Not only is helix α4 missing in Sma0114 but secondary structure prediction analysis
suggests that the absence of helix α4, or more rarely helix α5, is a conserved feature of
HWE-associated receiver domains. A possible role for flexibility in the segment

34

corresponding to helix α4 is to allow binding of downstream effectors through an
induced fit mechanism, thereby controlling the specificity of molecular association.
Residues Pro81 through Gly87 of the PFxFATGY motif, which form strand β4
and the beginning of the following loop, while rigid on the ps-ns timescale have raised
R2ex contributions consistent with dynamics on the µs-ms timescale. The exchange
contributions to R2 relaxation for these sites, suggest that they experience the dynamic
conformational equilibrium between the inactive and active substates of the enzyme that
is a hallmark of receiver domains (4, 39). The PFxFATGY sequence houses the
conserved Thr86 of the Y-T coupling mechanism. The partner aromatic residue for Y-T
coupling in Sma0114 is replaced by Leu103. In a previous study of the receiver domain
CheY, it was shown that the β4/α4 loop and the N-terminal portion of helix α4 constitute
the binding site for downstream effectors (47). Because part of the PFxFATGY motif in
Sma0114 occupies the same position in the structure as the β4/α4 loop region in CheY, it
is likely that Sma0114 has a similarly reduced binding site for downstream effectors. We
initially thought that the PFxFATGY sequence motif in Sma0114, may thus substitute or
circumvent the Y-T coupling mechanism typically used in receiver domains. NMR
analysis of the activated enzyme was necessary to explore this hypothesis in Chapter 4.
In spite of the differences in the 455 face, Sma0114 retains the ability to bind
divalent metal ions needed for activation. The residues in Sma0114 that experience the
largest chemical shift perturbations with increasing metal concentrations are consistent
with the binding site predicted based on sequence homology to other receiver domains
(Figure 3-6).
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Reprinted from Sheftic et al. (2013) (48)
I performed all experiments

Chapter Four. Characterization of Activated Sma0114

Abstract
Sma0114 is the first structurally-characterized representative from the family of
receiver domains that are substrates for HWE-kinases. Presented here is the NMR
structure of Sma0114 bound by Ca2+ and BeF3-, a phosphate analog that stabilizes the
activated state. Differences between the NMR structures of the inactive and activated
states occur in helix α1, the active site loop that connects strand β3 and helix α3, and in
the segment from strand β5 to helix α5 of the 455 face. In Sma0114 the structural
changes accompanying activation result in a more negatively charged surface for the 455
face. Coupling between the 455 face and active site phosphorylation is usually mediated
through Y-T coupling. NMR analysis indicates that Sma0114 lacks Y-T coupling, and
that communication between the active site and the 455 face is achieved through a
conserved lysine residue that stabilizes the acyl phosphate in receiver domains. 15NNMR relaxation experiments were used to investigate the backbone dynamics of the
Sma0114 the binary Sma0114•Ca2+ complex, and the ternary Sma0114•Ca2+•BeF3complex to complement the analysis of the apo protein. The loss of entropy due to ligand
binding at the active site is compensated by increased flexibility in the 455 face. The
dynamic character of the 455 face in Sma0114, which results in part from the
replacement of helix α4 by a flexible loop, may facilitate induced-fit recognition of target
molecules.
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Introduction
In order to gain insight into the changes in Sma0114 induced by activation we
solved the NMR structure of the enzyme in the activated state. Due to the fact that the
lifetimes of acyl phosphates (~ 30 min) are too short to allow detailed NMR studies, we
used the phosphate mimetic beryllium trifluoride (BeF3-) to stabilize the activated state,
as has been done for other structural studies of receiver domains (49, 50). The structures
of inactive and activated Sma0114 were analyzed for key differences that could
communicate the phosphorylation state of the receiver domain from the active site to the
455 face of the protein. We compared the conformational changes accompanying
activation of Sma0114 to three homologous single-domain receiver domains, to see what
features are conserved. Complementary 15N relaxation experiments were used to
investigate how the dynamics of Sma0114 are affected by binding Ca2+, and by activation
with Ca2+ and BeF3-.
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Results
NMR Structure of Activated Sma0114
Backbone (Cα, N, C') traces for the 26 lowest energy NMR structures of the
Sma0114•Ca2+•BeF3- ternary complex are shown in Figure 4-1A. Statistics pertaining to
the quality of the NMR structures are given in Table 4-1. The precision of the activated
NMR structure over elements of regular secondary structure is 0.71 Å, slightly better than
the 0.86 Å precision of the inactive state (31). Other measures of the quality of the
structure including the Procheck Z-score, RMS deviations from ideal geometry, and
average residual NOE violations are also slightly better for the activated than inactive
structure (31).
A cartoon showing the α4/β5 Rossmann fold topology of the activated structure is
shown in Figure 4-1B. As previously described for the structure of the inactive state in
Chapter 3, Sma0114 differs from typical receiver domains in having the fourth α-helix of
the 455 face replaced by a flexible loop. Interestingly, the fourth helix is also absent in
the structure of the activated state (Figure 4-1B). Thus binding of Ca2+ and BeF3- does
not induce folding of the fourth α-helix.
Figure 4-1C shows the active site, and key residues that interact with the Ca2+ and
Be3F- ions. The three residues Glu15, Asp16, and Glu17 in the loop between strand β1
and helix α1 (Lβ1α1) each have one oxygen within bonding distance of the Ca2+ ion (2.1,
2.1, and 2.4 Å). The Ca2+ ion is within bonding distance of two fluorine atoms from the
BeF3- molecule (1.8 and 2.1 Å).
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Figure 4-1 NMR Structure of the ternary Sma0114•Ca2+•BeF3- complex. (A) Stereodiagram of the 26 lowest energy NMR structures superimposed over regular main-chain
secondary structure elements: β1 (10-15), α1 (18-31), β2 (34-39), α2 (42-51), β3 (55-60),
α3 (70-78), β4 (81-86), β5 (102-104), α5 (110-118). (B) Backbone cartoon of the NMR
structure closest to the ensemble mean. (C) Sidechains that participate in ligand binding
at the active site of Sma0114 and Thr86. The Ca2+ ion is shown in purple and the BeF3molecule in pink and cyan.
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Table 4-1: Statistics for the 26 Lowest Energy NMR Structures of
Sma0114•Ca2+•BeF3NMR restraints (total)

1791

Distance (total)

1644

Intraresidue NOEs

472

Sequential NOEs

479

Short range NOEs (1< |i-j| < 5)

136

Long range NOEs (5 ≤ |i-j|)

495

Hydrogen bonds (31x2)

62

Dihedral (ϕ 70, ψ 61, χ1 16)

147

Residual restraint violations
NOE (Å)a

0.033 ± 0.0004

Dihedral (°)b

0.587 ± 0.075

RMS deviations from ideal geometry
Bonds (Å)

0.0037 ± 0.0002

Angles (°)

0.724 ± 0.004

Improper torsions (°)

0.560 ± 0.007

van der Waals energy (kcal/mol)c

87.85 ± 1.75

Lennard-Jones energy (kcal/mol)d

-85.42 ± 6.33

e

ProcheckNMR Z-score

-2.11

Ramachandran statistics for all residuese (and excluding loopsf)
most favored (%)

58.8

(58.2)

allowed (%)

29.6

(36.8)

generously allowed (%)

7.5

(4.9)

disallowed (%)

4.1

(0.0)

Coordinate RMS deviations (Å)
NMR ensemble to average

Cα, C, N

All Heavy

Entire domain (110 residues)g

0.88

1.34

Excluding loops (70 residues)f

0.71

1.19

NMR model to inactive model
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Entire domain (110 residues)g

1.91

2.70

Excluding loops (70 residues)f

1.66

2.32

_________________________________________________________________________

a

Structures have no NOE violations greater than 0.3 Å
Structures have no dihedral violations greater than 5°
c
Evdw was calculated using the X-PLOR Frepel function (34) with van der Waals interactions and
atomic radii set to 0.8 times their CHARMM (35) values.
d
EL-J was calculated using the CHARMM empirical energy function (35).
e
ProcheckNMR used via Protein Structure Validation Suite (PSVS) (36).
f
Only residues in regular secondary structure (10-15, 18-31, 34-39, 42-51, 55-60, 70-78, 81-86,
102-104, 110-118).
g
Excluding N-terminus (residues 1-9) and C-terminus (residues 119-123).
b

41

The third fluorine atom does not appear to form any bonding interactions. The fluorine
atom closest to the Ca2+ is 2.6 Å away from the Nz atom of Lys105. The positively
charged Nz atom of Lys105 may also be involved in an electrostatic interaction with the
OE2 atom of Glu15, with the two separated by 3.9 Å. The Be atom of BeF3- is bonded to
the OD2 atom of Asp60 (2.0 Å).

Conformational Changes Induced by the Activation of Sma0114
The structures of Sma0114 in the inactive and activated states, modeled by the
Sma0114•Ca2+•BeF3- ternary complex, are shown superimposed in Figure 4-2A. A plot
of the Cα RMSD after superimposition of the two structures is shown in Figure 4-2B.
The mean RMSD over all residues is 1.91Å (Table 4-1). Regions of the protein that show
larger differences than the mean RMSD are colored in pink and labeled (Figure 4-2A).
The largest difference is seen for the loop between strand β3 and helix α3 (Lβ3α3)
that partially covers the active site in the inactive structure but is in an open conformation
in the activated state. As expected, differences are seen in the 455 face. The C-terminus
of strand β5 becomes shorter by one residue, Lys105, which becomes part of Lβ5α5 in the
activated state. The C-terminus of strand β5 moves away from the core of the structure by
about 1.0-1.5 Å in the activated state, and undergoes a twist of about 30 degrees to align
better with strand β4. In the activated state, helix α5 undergoes a tilt of about 10-30
degrees to make it less parallel with the β-strands compared to the inactive structure.
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Figure 4-2 Comparison of the inactive and activated NMR structures of Sma0114. (A)
Stereo-diagram showing the least-squares superimposition of the inactive (grey) and
activated (cyan) structures. Residues with the largest RMS differences between the two
structures are indicated in pink on the activated structure. (B) Bar plot of Cα RMSD
values between the inactive and activated structures. Labels indicate the largest
differences between the two structures, with green and orange labels indicating segments
from the active site and 455 face, respectively.
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The helix also undergoes translational displacements in the activated state, including a
shift of 1.0 Å towards the top of the molecule (defined by the arrows indicating the Ctermini of the β-strands in Figure 4-2A) and a move of about 1.5 Å closer to the core of
structure. Outside of the 455 face, there are changes in α-helices 1 and 2 (Figure 4-2).
Helix α1 undergoes a bend in the activated structure which brings the last two turns about
1-2 Å closer to helix α5 and to the core of the structure. Similarly, helix α2 experiences a
10-20 degree axis tilt in the activated state, that brings the C-terminus of the α-helix
closer to the β-sheet core of the protein. Overall, the movement of α-helices 1 and 5
towards each other and the protein core, make the activated state structure slightly more
compact than the inactivated structure. The radii of gyration calculated from the
structures are 14.2 Å for the inactive and 13.8 Å for the activated states.

Comparison to Other Receiver Domains
To investigate the extent to which the changes associated with activation of
Sma0114 are conserved in other receiver domains, we looked at three single-domain
response regulators NtrC, CheY and Spo0F, shown in Figure 4-3. As in Figure 4-2, the
largest changes between the inactive and activated states are highlighted in pink on the
activated structures (Figure 4-3A) and bar graphs are used to summarize Cα RMSDs
(Figure 4-3B). The analysis shows that the conformational changes induced by the
activation of receiver domains can be quite variable.
In NtrC and CheY, conformational changes occur primarily along the 455 face of
the activated enzymes, particularly for helices α4 and α5.
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Figure 4-3 Structurally homologous single domain response regulators. (A)
Superimposition of inactive (grey) and activated (cyan) structures of NtrC (PDB codes
1NTR and 1KRX), CheY (PDB codes 5CHT and 1DJM) and Spo0F (PDB codes 1NAT
and 1PUX). Regions that show the largest differences upon activation are colored in pink
on the activated structures. (B) Corresponding Cα RMSD plots showing the largest
differences between the inactive and activated structures.
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Despite the absence of helix α4 in Sma0114 we do observe changes in the structure of
the β5 - α5 segment (Figure 4-2). The Spo0F receiver domain shows only small
differences for the 455 face, with the majority of structural changes occurring for the first
three α-helices outside of the 455 face (Figure 4-3) (38, 39). Like other single domain
response regulators shown in Figure 4-3, Sma0114 (Figure 4-2) shows structural changes
for helix α1 between the inactive and active states. This suggests that helix α1 could
participate together with the 455 face in binding downstream effectors, or alternatively
that it may be important in the transition to an activated state. Indeed, mutagenesis
experiments indicate that helix α1 of receiver domains plays a role in determining the
kinase specificity of receiver domains (51). The types of structural changes that occur
upon activation appear to follow similar trends. As in Sma0114, activation of the NtrC,
CheY, and Spo0F single domain receiver domains brings the α-helices closer to the βsheet core of the structures (Figure 4-3A). Another conserved theme is that helices α1
and α5 move closer together in the activated states (Figure 4-3A).
The largest changes observed between the inactive and activated states are in the
active site loops, particularly Lβ3α3 following the phosphorylation site (Figure 4-3B). In
all three structures, except CheY, where the differences are relatively small, Lβ3α3 moves
away from the active site in the activated state (Figure 4-3A). The open conformation of
Lβ3α3 was seen for NtrC (11) but the authors noted that the precision of that region in the
inactive structure precluded additional analysis. In Sma0114 the average RMSD for
residues comprising Lβ3α3 (Val61-Glu66) between the inactive and activated states is 3.2
Å. These RMSD values are much larger than the internal precisions of the structures
46

(RMSDs of 0.94 for the inactive (Table 3-1) and 0.88 for the activated structure (Table
4-1)). That the displacement of Lβ3α3 appears to be a conserved theme for the activated
states of receiver domains suggests that its open conformation plays an important role in
activation.

Sidechain Changes Accompanying Activation
An interesting question is how the phosphorylation state of the activated enzyme
is communicated to the 455 face in order to achieve the conformational transition that
prepares the receiver domain to bind its cognate effector proteins. Moreover, since
binding to partner molecules is likely to involve surface interactions, it is important to
characterize how activation affects the surface of the receiver domain.
In typical receiver domains, active site phosphorylation propagates structural
changes to the 455 face through Y-T coupling (1). Upon phosphorylation of a conserved
aspartate, a hydrogen bond forms via a Thr/Ser sidechain hydroxyl with the phosphate.
The displacement of a Thr/Ser leaves an internal cavity that is filled by the reorientation
of an Tyr/Phe residue from the surface to the interior of the structure (1). Thus, the
coupled rearrangement is the conformational change linking the active site and output
455 face. In Sma0114 the conserved threonine corresponds to Thr86. As shown in Figure
4-4A, Thr86 in strand β4 is in a nearly identical position before and after activation. The
hydroxyl oxygen of Thr86 is 7.0 Å away from the closest fluorine atom in BeF3-, and is
therefore too far to form a bond. Leu103 in strand β5 replaces the partner aromatic
residue for the Y-T coupling mechanism commonly seen in receiver domains.
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Figure 4- 4 Stereo-diagrams comparing selected sidechains between the inactive and
activated states of Sma0114. (A) The sidechain conformations of PFxFATGY motif
residues that show little change. (B) Sidechains that undergo large structural changes
between the inactive and activated conformations include Asp64 at the active site, and
Leu103, Lys105, Phe107 and Glu111 in the 455 face of the domain. The backbone trace
structure is shown for the activated state (gray). Sidechains from the inactive structure
are shown with yellow carbons while those from the activated state are shown with green
carbons.
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The sidechain of Leu103 does undergo a reorientation upon activation but from the
interior of the protein to the surface, the opposite of what is seen for the corresponding
aromatic residue in typical receiver domains. These observations suggest that like the
CheY2 receiver domain (37), Sma0114 lacks the Y-T coupling mechanism.
Based on the structure of the inactive protein, we proposed that the Y-T coupling
mechanism in Sma0114 may be substituted by the PFxFATGY sequence motif. This
sequence motif is highly conserved in the subfamily of receiver domains that are
substrates for HWE-kinases. As shown in Figure 4-4A, the PFxFATGY sequence motif,
which includes Thr86 and forms strand β4 of the Sma0114 structure, shows only minor
structural differences between the inactive and activated protein (also see Figure 4-2B).
Of the residues in the PFxFATGY motif, Thr86 comes closest to the BeF3- molecule,
through its Hα proton, which is 4.1 Å away. Given that there are no major structural
changes in the PFxFATGY motif between the inactive and activated structure it seems
unlikely that this motif plays a role in activation. Due to it's conservation in the HWEkinase associated subfamily it is possible that the PFxFATGY motif has a role in kinase
binding or is part of the modified surface of Sma0114 used to bind effector molecules.
Figure 4-4B shows the sidechains that experience the largest changes between the
inactive and activated structures. Lys105 is one of the residues with the greatest
perturbation. In the inactive state Lys105 forms a salt-bridge with Asp109 on the 455
surface of the domain. This salt bridge is broken in the activated structure, where the
Lys105 sidechain enters the interior of the protein to bind BeF3-. The repositioning of
Lys105 to the interior of the domain is accompanied by the displacement of Leu103 in
strand β5 from the interior towards the surface of the structure. The cavity left by the
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displacement of Leu103 is filled by Lys105 and by the aromatic ring of Phe107 from
loop Lβ5α5. The movement of Phe107 leaves room for Glu111 to switch from a position
on the surface exposed side of helix α5 to one that bridges the gap between helices α5
and α1. Part of what may contribute to bringing helix α1 closer to the β-sheet core of the
protein is an electrostatic interaction between His33 NE2 and Asp55 OD1, which are 4.3
Å apart in the activated state versus 8.2 Å apart in the inactive structure.
Outside of the 455 face, large changes in sidechain positions are found at the
active site. These include Glu17, which moves from a surface position towards the
interior of the structure to act as a ligand for the Ca2+ ion. Large changes are also seen for
the entire loop Lβ3α3, spanning residues Val61-Glu66, which moves away from the
active site to an 'open' conformation in the activated structure (Figure 4-4B). The
displacement of Lβ3α3 in the activated structure may be due to steric occlusion from the
BeF3- molecule, Ca2+ ion, and the ligating residues from the protein that move into the
active site. Electrostatic repulsion between Asp64 at the center of this loop and the high
density of negatively charged groups in the active site (Glu15, Asp16, Glu17, Asp60)
may also contribute to the displacement of the loop.
The sidechain changes accompanying activation of Sma0114 lead to changes in
the surface properties of the 455 face, as shown in Figure 4-5. Sma0114 has a
predominantly anionic character with a pI of 4.5, due to an excess of 21 acidic over 11
basic residues. Most of the surface of Sma0114 is negatively charged, except for a
positively charged patch corresponding to the exposed sides of helices α2 and α3.
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Figure 4-5 Electrostatic potential surface for the 455 face in (A) the inactive domain and
(B) the activated domain. Red and blue correspond to negative and positive electrostatic
potentials, respectively. The positions of Asp64, Asp109, and helix α1 are indicated on
the surfaces. Electrostatic potentials were calculated with the APBS server (52).
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This unusual charge distribution is unique to Sma0114, and is not a feature shared with
other receiver domains. The views in Figure 4-5 show the 455 face in front. The ridge to
the right below the 455 face, is due to helix α1. The interface between helices α1 and α5
that closes the Rossmann fold structure has a high density of negatively charged residues.
Activation of Sma0114 appears to increase the negative character of the 455 surface. This
is particularly evident near Asp109, which is labeled in Figure 4-5. In the inactive state
(Figure 4-5A) the charge on Asp109 is complemented by a salt bridge with Lys105.
Upon activation Lys105 switches to the interior of the protein to bind BeF3-, leaving the
negative charge on Asp109 exposed (Figure 4-5B). Other more subtle changes such as
partial burial of the basic residues Lys91 and Arg96 also contribute to the display of a
more negatively charged 455 surface in the activated state (Figure 4-5B).

Effects of Ca2+ and BeF3- Binding on Backbone Dynamics
Figure 4-6 shows S2 order parameters, that describe the amplitudes of backbone
HN motions on the ps-ns timescale, for inactive Sma0114 (Figure 4-6A) , the
Sma0114•Ca2+ binary complex (Figure 4-6B), and the activated Sma0114•Ca2+•BeF3ternary complex (Figure 4-6C). The active site loops, Lβ1α1 and Lβ3α3 that contribute
ligands to Ca2+ and BeF3-, show average S2 order parameters. The lack of ps-ns motions
in these loops indicate a lack of dynamic flexibility for these regions in the inactive state
(Figure 4-6A). As we only have data on backbone dynamics, this does not exclude
increased sidechain flexibility for these residues. In the inactive protein (Figure 4-6A),
low S2 order parameters indicative of backbone flexibility occur at the chain termini and
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in the portion of loop Lβ4β5 that corresponds to helix α4. The chain termini, and residues
(Lys91, Gly92, Leu93) in the loop retain low S2 terms in the all three states. Thus the
region corresponding to helix α4 remains unfolded in the metal-bound and activated
states.
Backbone flexibility is increased at a number of sites in the Sma0114•Ca2+ binary
complex (Figure 4-6B) compared to the inactive protein (Figure 4-6A). This includes
residues Met19 and Leu24 following the metal binding site in helix α1. In the 455 face
increased mobility is seen for residues Leu102 in strand β5 and Val115-Val117 at the end
of helix α5. The enhanced backbone dynamics in regions of the protein remote from the
binding site, suggest an entropy-compensated binding mechanism (53-56), where the
ordering of the Ca2+-binding site is offset by increased mobility in other parts of the
molecule.
Data on the backbone dynamics for the activated state, stabilized by the binding
of Ca2+ and BeF3- are shown in Figure 4-6C. The S2 order parameters of the inactive and
activated protein are mapped on their corresponding structures in Figure 7. Mobility in
helix α1 is reduced in the activated state (Figure 4-6C) compared to the Ca2+-bound state
(Figure 4-6B); except for residues Ile20 and Met22 immediately following the Ca2+
binding loop, which show intermediate order parameters (Figure 4-7). Like the Ca2+bound state, the activated state shows flexibility for residues in the 455 face, although
there are some subtle differences compared to the former. In the activated state residues
Thr104-Phe107 in loop Lβ5α5 show raised mobility whereas in the Ca2+-bound state
residue Leu102 in strand β5 is mobile (Figure 4-6B, 4-6C).
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Figure 4-6 S2 order parameters for Sma0114 in the apo state (A) the Ca2+ binary
complex (B) and the Ca2+•BeF3- ternary complex (C). The correlation times for each state
were 5.6 ns for A, 5.9 ns for B, and 5.7 ns for C. A secondary structure diagram with αhelices represented by cylinders and β-sheets by arrows is shown in (A). Segments of the
protein that show low S2 order parameters are labeled in each panel.
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Interestingly, the residue with the highest backbone mobility in loop Lβ5α5 of the
activated state is Lys105, whose sidechain binds BeF3-. Like the Ca2+-bound protein, the
activated state exhibits low S2 order parameters for residues Val115-Val117 at the Cterminal end of helix α5.
Figure 4-8 shows R2ex line-broadening contributions for the three states obtained
from Model-Free calculations (32, 42, 57). In both the apo protein (Figure 4-8A) and in
the Ca2+-bound state (Figure 4-8B) there are four regions that have large R2ex terms
indicative of conformational exchange on the µs-ms timescale. These are (I) the metal
binding loop (Lβ1α1), (II) Lβ3α3 following the site of phosphorylation Asp60, (III) the Cterminal region of strand β4, and (IV) the β5-Lβ5α5 segment that holds Lys105, which
stabilizes the acyl-phosphate moiety. R2ex contributions for these regions have been
described in other receiver domains, and have been attributed to a dynamic equilibrium
between the inactive and active conformations (6, 20). Consistent with previous work on
other receiver domains (6, 20), the R2ex terms for regions I-IV in Sma0114 decrease as
the equilibrium is shifted in favor of the activated state, by binding Ca2+ and BeF3(Figure 4-8C). The large number of R2ex terms between 0 and 5 Hz for the activated state
are an artifact of lower precision 15N relaxation data. The relatively high salt
concentration of 30 mM NaF, needed to generate BeF3- in the sample, reduces the
sensitivity of the relaxation data.
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Figure 4-7 S2 Order parameters mapped onto the NMR structures of (A) inactive and (B)
activated Sma0114. The data are from Fig. 4-6A and 4-6C. The S2 values are represented
with a ROYGBIV seven-color gradient with red being the most flexible 0.00 ≤ S2 ≤ 0.14
and violet the least flexible 0.84 < S2 ≤ 1.00. In the inactive structure, flexibility is
predominantly associated with the loop Lβ4β5 which replaces the canonical receiver
domain fold helix α4 in Sma0114 (A). In the activated domain the loop Lβ4β5 remains
flexible and additional flexibility is seen for residues in helix α1, loop Lβ5α5, and helix α5,
with the latter two belonging to the 455 face of the domain. Residues experiencing the
greatest change in flexibility, Thr104, Lys105, Val115 and Leu116, are labeled on the
activated structure. The phosphorylation site (Asp60) is labeled in (A) and (B).
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Figure 4-8 R2ex contributions for (A) apo-Sma0114 (B) the Sma0114•Ca2+ binary
complex and (C) the Sma0114•Ca2+•BeF3- ternary complex. The secondary structure is
shown in (A). The apo domain (A) shows four regions with raised R2ex values: (I) the
metal-binding site, (II) the phosphorylation site, (III) the C-terminal end of strand β4, and
(IV) the junction between stand β5 and helix α5. The R2ex contributions persist when
Ca2+ is bound (B) but are suppressed in the Sma0114•Ca2+•BeF3- ternary complex.
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Discussion
Phosphorylation causes a conformational switch that enables a receiver domain to
bind downstream target molecules (5). The duration of the output response, which can
range from seconds to hours, is regulated by the lifetime of the acyl phosphate linkage
that induces the conformational transition to the activated state. In the current study we
stabilized the activated state of Sma0114 by binding Ca2+ and the phosphate analog BeF3, as has been done in other studies of receiver domains (37, 50) due to the limited lifetime
of the acyl phosphate. In the present work we describe the NMR structure and dynamics
of the activated form of Sma0114 to provide a more complete picture of the activation
mechanism of this enzyme that is prototypical for the family of receiver domains
activated by HWE-kinases.
A large difference between the structures of inactive and activated Sma0114
occurs in the loop Lβ3α3. In the inactive state this loop folds over the active site, partially
occluding it (Figure 4-2A). Our active state structure shows that Lβ3α3 retains an open
conformation in the activated state that leaves the active site more exposed compared to
the inactive state (Figure 4-2A). One possible advantage of having Lβ3α3 displaced from
the active site is that it could facilitate a water molecule entering the active site to
perform hydrolysis of the phosphate group. The release of the phosphate-leaving group
after the autophosphatase activity of Sma0114 would also be facilitated by the open
Lβ3α3 that exposes the phosphorylation site Asp60. As such, loop Lβ3α3 could participate
in determining the lifetime of the activated state before the enzyme switches back to its
inactive state.
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A key question in the structural biology of receiver domains is how
phosphorylation of the conserved aspartate induces the conformational switch needed to
bind downstream effector molecules. Typically the initial conformational switch occurs
through Y-T coupling when a threonine at the C-terminal end of strand β4 repositions to
hydrogen bond to the phosphate. The movement of the threonine allows the reorientation
of an aromatic residue (typically a tyrosine) in strand β5 from the surface of the 455 face
to the interior of the protein, thus propagating conformational changes from the active
site to the 455 face (1). In Sma0114 Thr86, corresponding to the threonine in Y-T
coupling, is too far from the active site to hydrogen bond to the phosphate and shows
little structural difference between the inactive and activated states (Figure 4-4A). The
conserved aromatic residue is replaced by Leu103, which switches from the inside to the
outside of the Sma0114 structure on activation, the opposite of what is seen for the
aromatic residue in classical Y-T coupling. Receiver domains that are substrates for
HWE-kinases have a highly conserved PFxFATGY sequence motif that encompasses the
threonine of Y-T coupling, Thr86 in Sma0114, and we proposed that it could be used as
an alternative for communication between the active site and the 455 face (31). The NMR
structure of the activated state, however, shows that residues of the PFxFATGY motif in
strand β4 retain similar conformations to those seen in the inactive state, and are too far
away from the active site to substitute for the Y-T coupling mechanism (Figure 4-4A).
We can conclude that Y-T coupling is eliminated in Sma0114 and the conserved
PFxFATGY motif appears not to be an alternative conduit of communication between the
active site and output response face.
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The only interaction between the 455 face and the active site that to our
knowledge is conserved in all receiver domains, is that between Lys105 in loop Lβ5α5
and the phosphate or BeF3- ion. In the activated state of Sma0114, the repositioning of
Lys105 to bind BeF3- is accompanied by a number of changes that affect the 455 face.
These include a displacement of Leu103 in strand β5 from the interior to the surface of
the protein, and movements of Phe107 and Glu111 towards the interior of the protein that
bring helix α5 closer to the β-sheet core and to helix α1 in the activated structure.
Although the role of Lys105 has traditionally been viewed as stabilizing the acyl
phosphate (4), it also seems the most likely candidate to effectuate the communication
between the active site and 455 face of Sma0114.
Because different receiver domains recognize a variety of downstream targets the
structural changes accompanying activation are variable. In most receiver domains the
largest changes induced by activation occur on the 455 face (Figure 4-3), however, this is
not always the case. Activation of the bacterial sporulation factor Spo0F leaves the 455
face relatively unchanged. The largest structural changes occur in helix α1 (Figure 4-3),
and these have been shown to play important roles in protein-protein interactions with the
downstream targets of Spo0F (39). Activation of Sma0114 leads to structural changes in
strand β5 and helix α5 of the 455 face (Figure 4-2), with the important difference that
helix α4 of the typical receiver domain fold is replaced by a flexible loop. Additional
changes extend to helix α1, which is also perturbed in the activated state of the three
receiver domains NtrC, CheY, and Spo0F (Figure 4-3). We cannot identify if the
rearrangement of helix α1 in Sma0114 occurs after Ca2+ binding or BeF3- binding,
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although the perturbed conformation is maintained in the fully activated enzyme.
Therefore, helix α1 may have a role in priming the enzyme for phosphorylation or
participate in the output response by binding effectors in the fully activated state.
Changes in secondary structure elements accompanying activation must lead to changes
in the surfaces of receiver domains that enable them to bind their downstream target
molecules. In the case of Sma0114, the sidechain rearrangements that accompany
activation give the 455 face a more negatively charged character (Figure 4-5) that could
be used to select positively charged target molecules.
Receiver domain dynamics on slow µs-ms timescales have been investigated
using relaxation dispersion methods (6, 20, 58). These studies showed that the inactive
and activated conformations exist in a dynamic equilibrium, that is shifted in favor of the
activated state when the active site binds ligands (6). Our results for Sma0114 are
consistent with this two-state allosteric mechanism of activation. The apo (Figure 4-8A)
and Ca2+-bound enzyme (Figure 4-8B) exhibit R2ex line-broadening contributions for
NMR signals from residues in the active site and 455 face. The R2ex contributions are
suppressed in the Sma0114•Ca2+•BeF3- ternary complex, where the population of the
activated state dominates (Figure 4-8C).
By contrast, there have been few studies of receiver domain dynamics on the fast
ps-ns timescales accessible by 15N relaxation measurements. Spo0F was characterized
only in the apo-state where dynamics on the ps-ns timescale were shown to be constant
except at the chain termini (19). For NtrC, ps-ns dynamics were characterized for both
the inactive and activated forms of the enzyme, and were shown to be constant except at
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the chain termini (6). In the case of Sma0114 we characterized ps-ns dynamics for three
forms of the protein: the apo-state, the Ca2+-bound state, and the activated state (Figure 46). Both the Sma0114•Ca2+ binary complex (Figure 4-6B) and the Sma0114•Ca2+•BeF3ternary complex (Figure 4-6C) show an increase in the number of residues exhibiting
flexibility on the ps-ns timescale compared to the apo-protein (Figure 4-6A). These
results suggest an entropy-compensated binding mechanism for the BeF3- phosphate
analog, where the decrease in entropy due to ligand binding in the active site is
compensated by increased dynamics in other parts of the structure. Entropy-compensated
binding was first hypothesized in 1963 for insulin dimerization (53). The mechanism has
since been supported by NMR relaxation studies showing increased dynamics
accompanying ligand binding in a number of proteins (54, 55, 59), including the enzymes
MutT (56), stromelysin (60), and topoisomerase I (61).
In the case of Sma0114, entropy-compensated binding is likely to be exploited for
a functional role, as most of the residues that show increased dynamics in the activated
state are part of the 455 face of the protein. These include residues Thr104-Phe107 in
strand β5 and loop Lβ5α5 and Val115-Val117 in helix α5. The mobile loop, (Gly89Leu93) that replaces helix α4, together with the above segments give the 455 face in
Sma0114 a flexible character (Figure 4-7B). Flexibility in the 455 face could be used to
bind downstream effector proteins through an induced-fit mechanism, initially proposed
by Dyson and Wright (62, 63). In an induced-fit mechanism, weak interactions with
diffuse specificity are first formed using the dynamic segments of a binding surface and
strengthen as the appropriate ligand is drawn closer to the receptor and the complement
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of correct interactions are formed. The dynamically disordered surface in Sma0114 may
facilitate binding a range of molecules each having a common molecular shape
recognized by the 455 face.
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Chapter 5. Materials and Methods
Sma0114 Expression and Purification.
The sma0114 gene was amplified from S. meliloti strain Rm1021, cloned into the
pET28(+) plasmid, and transformed into Escherichia coli strain BL21(DE3)pLysS. Cells
were grown in 1 liter of M9 medium containing 1.0 g 15N-NH4Cl and/or 3 g of 13Cglucose supplemented with kanamycin to a final concentration of 25 µg/ml. Following
incubation at 30°C to mid-log phase, the recombinant His-tagged Sma0114 protein was
induced by the addition of isopropyl β-D-1 thiogalactopyranoside (IPTG) to a final
concentration of 0.5 mM. Cells were harvested 18 hours after induction and lysed by
sonication in affinity column binding buffer (100 mM Tris-HCl, 0.5 M NaCl, pH 7.4)
containing lysozyme and 1 mM phenylmethanesulfonyl (PMSF). The cell debris was
sedimented and the His6-Sma0114 fusion protein in the supernatant was purified by
nickel affinity chromatography on a 1 ml HisTrap column. Following elution, fractions
containing His6-Sma0114 were pooled and cleaved overnight at 23°C with 10U/ml of
bovine thrombin. PMSF was subsequently added to inactivate thrombin, and the
Sma0114 component was further purified by gel filtration on a Superdex S75 column.
The fractions eluted from this column were run over a 1 ml HisTrap column to remove
any uncut His6-Sma0114. The remaining flow-through containing Sma0114 at > 95%
purity by SDS-PAGE, was dialyzed extensively against the buffer used for NMR (50 mM
sodium phosphate pH 6.0). Following dialysis, samples were concentrated for NMR
using 10,000 molecular weight cut-off centrifugal filter units.
The Sma0114 construct used for these studies contains the extra three N-terminal
residues Gly-Ser-His from the thrombin cleavage site used to purify the protein. These
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residues are included in our numbering scheme for the protein, which runs from residues
Gly1 to Val123 with only residues Met4-Val123 part of the wild type Sma0114 amino
acid sequence. We did not detect NMR signals from the amide protons of the extra
residues Gly1-His3, suggesting they are disordered.

NMR Sample Preparation
NMR samples of the inactive enzyme were dissolved in 50 mM sodium phosphate
pH 6.0 supplemented with 0.02% NaN3 to prevent bacterial growth and 1 mM
dithiothreitol (DTT) to prevent disulfide formation due to the sole cysteine at position 29
in the protein. For NMR spectroscopy on the activated enzyme, 15N-Sma0114 and
15

N,13C-Sma0114 samples were dissolved in 50 mM 2-(N-morpholino)ethanesulfonic

acid (MES), buffered to pH 6.0. MES buffer was used for experiments on the binary
Sma0114•Ca2+ and ternary Sma0114•Ca2+•BeF3- complexes rather than phosphate, to
prevent precipitation of Ca2+. Samples had 500 µM concentrations of protein. All NMR
experiments were done at a temperature of 37°C. NMR metal titrations were performed
using 15N-labeled samples of Sma0114, over a range of concentrations between 0 and 500
mM MgCl2. Due to the high 150 mM concentration of MgCl2 needed to saturate the
enzyme, we also looked at the binding of CaCl2 over a concentration range between 0 and
10 mM. With CaCl2, saturation of Sma0114 was achieved at a metal ion concentration of
1.5 mM.
The Sma0114•Ca2+•BeF3- ternary complex was prepared using the approach of
Yan, et al. (49). BeF3-, generated in situ from the addition of NaF to BeCl2, mimics the
acyl phosphate linkages formed by the active site aspartates of receiver domains (11, 39,
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49, 50). Starting from samples of Sma0114 containing 1.5 mM CaCl2, we added NaF in
increments of 5 mM and observed no changes in 1H-15N HSQC spectra of the protein up
to a final concentration of 30 mM NaF. Thus the presence of NaF, which is needed to
generate BeF3- from BeCl2, does not perturb the structure of Sma0114. We next added
BeCl2 in 1 mM increments and found that a 5 mM concentration was sufficient to
saturate the active site, as monitored by the point at which no further chemical shift
changes were seen in 1H-15N HSQC spectra. Thus the final sample conditions for the
Sma0114•Ca2+•BeF3- ternary complex were 500 µM Sma0114, 1.5 mM CaCl2, 30 mM
NaF, and 5 mM BeCl2.

Inactive Sma0114 Nuclear Magnetic Resonance Spectroscopy
Samples of 250 µl volumes were taken up Shigemi microcells. Spectra were
recorded on a Varian INOVA 600 MHz spectrometer equipped with a cryogenic probe.
The temperature for all experiments was 37°C. NMR assignments were obtained using
2D and 3D experiments (64) implemented in the Varian Protein Pack. Starting from the
2D 1H-15N HSQC spectrum, backbone 1H, 15N and 13C resonances were assigned using
two redundant sequential walk pathways. The first used 3D HNCACB, HNCA and
HN(CO)CA data to establish Cα and Cβ connections across peptide bonds. The second
pathway used HNCO and HN(CA)CO experiments to connect C’ carbons across peptide
bonds. Sidechain assignments were obtained from 3D HCCH-TOCSY, H(CCO)NH,
C(CO)NH, HNHA, HNHB, 1H-15N TOCSY-HSQC, and 1H-13C HSQC-NOESY data.
Stereo-specific assignments for methylene protons were based on short mixing time (25
ms) 2D NOESY, 3D 1H-15N NOESY-HSQC and HNHB experiments as described (65).
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Aromatic 1H and 13C resonances were obtained from 2D 1H-13C HSQC, DFQ-COSY and
TOCSY data. 2D NOESY experiments (150 ms mixing time) using a sample in D2O
were used to connect aromatic resonances with previously assigned aliphatic resonances.
Sidechain amide resonances were linked through intra-residue NOEs to previously
assigned aliphatic protons using 3D 1H-15N NOESY-HSQC data. DSS was used as an
internal reference for 1H resonances, and 13C and 15N resonances were referenced
indirectly (66). Spectra were processed and analyzed using FELIX-NMR and iNMR.
The limits of secondary structure elements were determined using 3JHNHα - coupling
constants (67), TALOS chemical shift analysis (29) and hydrogen-deuterium exchange
data.

Inactive Sma0114 Chemical Shift Assignments
1

HN, 15N, 13C’, Cα, Cβ, Hα and Hβ resonances were assigned for 94% of the

amino acids in Sma0114. In total, we obtained assignments for 84% of all carbons (90%
of aliphatic carbons and 65% of aromatic carbons), 84% of all protons (84% aliphatic and
85% of aromatic protons) and 75% of all nitrogens. Four of 118 non-proline residues
were not observed in the 1H-15N HSQC spectrum: Leu108, and residues Gly1-His3 which
are not part of the wild type sequence but were introduced as part of a thrombin cleavage
site used in purification of Sma0114. Chemical shift assignments are deposited in the
Biological Magnetic Resonance Bank (http://www.bmrb.wisc.edu) under accession code
BMRB-16905.
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Chemical shifts for the Activated Enzyme
The 2D 1H-15N HSQC of the inactive enzyme (Figure 2-2) was used as a
reference for assigning resonances in the ternary Sma0114Ca2+BeF3- complex. Having
complete assignments for the inactive protein (Chapter 2) facilitated NMR assignments
for the active form since only a subset of resonances undergo changes upon activation.
Figure 5-1 shows chemical shift changes in 1H-15N HSQC spectra for the Ca2+-bound
enzyme (A) and the fully activated (Ca2+ and BeF3- bound) enzyme (B).
Changes in sidechain chemical shifts for the activated enzyme were determined
from 13C-HCCH-TOCSY spectra which correlates all side-chain protons with alpha or
beta protons of individual amino acids while allowing the assignment of sidechain
carbons (68). Chemical shift assignments for the Sma0114•Ca2+•BeF3- ternary complex
have been deposited in the BMRB database under accession code 19286.

NMR Structure Determination for Inactive Sma0114
3D 15N- and 13C-editted NOESY experiments (64) were used to obtain NOEbased distance restraints. Long-range HNCO (69) and deuterium isotope exchange
experiments were used to identify hydrogen bonds. Restraints for the backbone dihedral
angles φ and ψ were calculated from the assigned HN, Hα, N, Cα, Cβ and C’ chemical
shifts using the program TALOS (29). Additional 3D HNHA data were collected to
check φ dihedral angles. Side-chain χ1 dihedral angles and stereospecific assignments
for prochiral methylene protons were determined from 3D HNHB data (64) and shortmixing time 2D NOESY spectra (65). Stereospecific assignments for the prochiral methyl
groups of Leu and Val residues were obtained from a sample fractionally labeled with

68

10% 13C-glucose (70). NMR spectra were collected on a Varian Inova 600 MHz
instrument equipped with a cryogenic probe. The NMR structure of Sma0114 was
calculated using the program X-PLOR (v. 3.851) (34) based on 1627 experimental
restraints (Table 3-1). The 20 lowest energy structures have been deposited in the PDB
under accession code 2LPM.

NMR Structure Determination for BeF3- activated Sma0114
Chemical shifts for the Sma0114•Ca2+ binary complex were obtained from the
titration of 1H-15N crosspeaks in 2D 1H-15N HSQC spectra of Sma0114 as a function of
CaCl2 concentration (31). NMR assignments for the Sma0114•Ca2+•BeF3- ternary
complex were made from 2D and 3D NMR experiments as previously described for the
apo protein. Distance restraints for structure calculations were obtained from 3D 15N- and
13

C-edited NOESY experiments (64) collected on a Varian Inova 800 MHz instrument,

and a 2D 1H-NOESY experiment for the aromatic protons recorded at 600 MHz. The
mixing time for all NOESY experiments was 150 ms. Hydrogen bonds were identified
from deuterium isotope exchange experiments recorded on the ternary complex dissolved
in 99.96% D2O. Hydrogen bond donors were identified as those residues seen in 1H-15N
HSQC spectra after deuterium isotope exchange. The protection pattern for the activated
state was compared to that seen in the inactive enzyme and no changes were identified.
We therefore determined that the hydrogen bond donors and acceptors did not change
due to activation. Backbone φ and ψ dihedral angles were calculated from the assigned
HN, Hα, N, Cα, Cβ and C’ chemical shifts using the program DANGLE in CCPNMRanalysis (71).
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Figure 5-1 (A) 1H-15N HSQC of the free protein (black) and the Ca2+ - bound protein
(red). (B) 1H-15N HSQC of the Ca2+ - bound (red) and the BeF3- activated protein (green).
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The NMR structure of the activated Sma0114•Ca2+•BeF3- ternary complex, was
calculated using the program X-PLOR (v. 3.851) (34) based on 1791 experimental
restraints (Table 4-1). Calculations were performed using Ca2+, Be, and F atomic radii
from the X-PLOR library (34) to include the divalent metal ion and BeF3-. Because there
are no literature examples available for a bond between Ca2+ and BeF3-, we set the
distance restraint between the two atoms at 2.35 Å, equal to the sum of the ionic radii for
Ca2+ (0.99 Å) and F- (1.36 Å). The distance restraint was given an uncertainty bound of
0.1 Å and the three fluorine atoms in BeF3- were treated as ambiguous. We next included
an ambiguous restraint of 1.5 ± 0.3 Å between the two sidechain carboxylic acid oxygens
of Asp60 (OD1 or OD2) and the beryllium atom. The restraint was based on distances
between the beryllium atom and the closest oxygen of the equivalent aspartate in
representative X-ray structures of receiver domains (PDB codes: 1FWQ, 2A9O, 2PL1,
3NNN). Bond distances in these structures ranged from 1.5 to 2.0 Å, with an average
distance of 1.7 Å. We used the same approach to restrain the three possible Ca2+ ligands
in the protein, Glu15-Asp16-Glu17. An analogous stretch of two, or three acidic residues
in a row is found in the receiver domain structures listed above. To determine which of
the three acidic residues in Sma0114 could be ligands for Ca2+, we carried out structure
calculations with the distance restraint set for the complete structure but excluding
restraints to Ca2+ or BeF3-. Superimposition of the two structures showed that both Glu15
and Asp16 were within bonding distance of the Ca2+ atom in the structures calculated
without restraints to the ligands. These two residues are also within bonding distance to
the Ca2+ atom in the apo enzyme, determined from a comparison of the NMR structures
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of inactive and activated states (31). That is, the two residues already appear to be
positioned to bind the metal in the inactive apo state. Glu17 points away from the Ca2+
atom but the conformation of this residue is poorly defined due to R2 line broadening.
We therefore decided to also include Glu17 as a potential Ca2+ binding ligand. Distance
restraints were set to 2.45 ± 0.15 Å based on literature values of typical bonds between
carboxylic acid groups and Ca2+ in known protein structures (72), which range between
2.3-2.6 Å. The distance restraints where treated as ambiguous with respect to the oxygens
bound to the Ca2+ atom: Glu15 (OE1 or OE2), Asp16 (OD1 or OD2), and Glu17 (OE1 or
OE2). Finally, we introduced a restraint of 2.5 ± 0.5 Å between the NZ atom of Lys105
and the fluorine atoms of BeF3-, which were treated as ambiguous in the calculations. An
analogous lysine is found bound to BeF3- in all BeF3- activated receiver domain
structures, with a bonding distance between 2.8 and 3.0 Å. To test the effect of this
restraint we calculated a set of structures in which only the Lys105-BeF3- restraint was
removed. Without the restraint, the lysine sidechain was positioned in the interior of the
structure but the distance of 6.0 Å to BeF3- precluded a bonding interaction. Given that a
buried charged lysine would be highly energetically unfavorable (73) as there are no
other nearby negatively charged groups that could complement the positive charge on
Lys105, we felt the restraint to the BeF3- ion was justified. The restraints from the protein
to the Ca2+ and BeF3- ligands described above, introduced no violations in the structure
calculations. The RMSD between the structures calculated with and without restraints to
the ligands was 0.80 Å, comparable to the 0.88 Å value for the spread in the ensemble of
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activated state NMR structures (Table 4-1). This indicates that the derived restraints to
the ligands do not affect the overall structure, and that the structure with the restraints to
the ligands is compatible with the experimental NOE, hydrogen-bond, and dihedral
restraints. The 26 lowest energy structures for the activated state of Sma0114 have been
deposited in the PDB under accession code 2M98.

NMR Relaxation Measurements
Backbone dynamics of Sma0114 were investigated using 15N R1, R2 and 1H-15N
NOE experiments. Longitudinal relaxation rates (R1) were characterized using
relaxation delays of 0.02, 0.05, 0.13, 0.21, 0.31, 0.5, 0.71 and 1.0 s. Transverse relaxation
rates (R2) were measured using relaxation delays of 0.01, 0.03, 0.05, 0.07, 0.09, 0.15,
0.25 and 0.35 s. 1H-15N NOE values were determined from experiments in which the
proton signals were saturated (s) for 4 s and control experiments (c) in which the
saturation period was replaced by an equivalent preacquisition delay. Spectra were
acquired in an interleaved manner on a Varian Inova 600 MHz instrument for all three
relaxation data sets. Relaxation rates were calculated from least-squares fits of the data to
an exponential decay model (Eq. 1) where I is the intensity for the relaxation period τ, I0
is the initial amplitude and R1,2 corresponds to the relaxation rate R1 or R2.

I = I0exp(-τ/R1,2)

Equation 1

Experimental uncertainties in relaxation parameters were taken as the standard errors of
the fits. 1H-15N NOE values were calculated according to Equation 2, where I(s) is the
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crosspeak intensity in the experiment with saturation (s) and I(c) is the crosspeak
intensity without saturation (c).

NOE = I(s)/I(c)

Equation 2

The errors for the 1H-15N NOE experiment were determined as described previously (57,
74). R1, R2 and 1H-15N NOE values were used as input for Model-Free calculations (42)
using the program Tensor2 (32).

Bioinformatics Analysis of Sma0114
Analysis of 273 HWE-kinases collected from the MiST 1 database (75) showed
that 88 of the kinases had associated receiver domains. Receiver domains were
considered to be associated with an HWE-kinase if the genes were fused or immediately
upstream or downstream of the kinase. The cognate receiver domains of the 88 HWEkinases identified in this way, were analyzed using the secondary structure prediction
program PsiPred (v 2.6) (43). The final alignment excluded 5 of the 88 sequences
because they were less than 100 amino acids in length and did not appear to encode fulllength receiver domains. As a control, 8 receiver domain sequences of known structure
were employed in the alignment to verify that the α5/β5 motif could be detected
accurately by PsiPred (43).
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Chapter 6. Future Directions

Identifying the downstream target that Sma0114 interacts with remains a key
objective. Complementary genetic and bioinformatics work on the downstream function
of Sma0114 is underway. A deletion mutant removing the gene for Sma0114
(Δsma0114) led to increased gene transcription in S. meliloti whereas deleting the
Sma0113 HWE-kinase (Δsma0113) and a double mutant (Δsma0113sma0114) led to no
change in gene transcription. Taken together these data show that Sma0114 requires
functional Sma0113, its cognate histidine kinase, in order to exert its phenotype. Current
studies building off of these results suggest that the primary role of Sma0114 is to inhibit
Sma0113. The working theory is that phosphorylation of Sma0113 induces the
phosphorylation of Sma0114 and leads to dissociation of the two proteins. Once
Sma0114 is dissociated from Sma0113, Sma0113 is able to activate another receiver
domain protein. Genetic analysis should be performed to identify other receiver domain
partners that may be involved in a phospho-relay with Sma0113 once the kinase is
phosphorylated.
In light of the fact that the inhibition of Sma0113 may be the primary role of
Sma0114, further studies on the structure of Sma0113 should be performed. A necessary
first step is to make Sma0113 soluble because its insolubility has precluded analysis of
the enzyme's structure and function. The role of the His, Trp and Glu residues important
in the HWE-kinase subfamily should also be explored in Sma0113. Mutants for these
residues should be designed. In this way parallel mutant experiments can be compared to
those done for the HWE-kinase BphP2 (18) to determine the importance of the three
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residues in phospho-transfer. In BphP2 point mutations for each HWE residue eliminated
autophosphorylation (18), so that we would expect to see a similar profile in Sma0113.
Structural analysis of Sma0113 would enable an in-depth study of the role of each residue
in the 3-dimensional form of the enzyme. Comparison of HWE-kinases to the histidine
kinase superfamily would also be accomplished by solving the structure of Sma0113.
Furthermore, titrating Sma0113 into 15N-labelled Sma0114 and recording changes in the
1

H-15N HSQC of Sma0114 can help define the interface between the two enzymes.
In order to explore the role of Lys105 in Sma0114 as the conduit of

communication between the active site and 455 face, the residue should be mutated. A
Lys105Arg mutant can be designed to maintain a positive charge at the position to test if
any basic residue will function as a conduit. A Lys105Leu mutant would allow us to
further test the importance of the positive charge at that position. In these mutants the
ability to bind BeF3- as well as conformational changes in the 455 face should be
determined. 15N relaxation experiments can be used to explore ps-ns dynamics and
compare S2 order parameters of wildtype Sma0114 and Lys105 mutants.
The role of residues in the PFxFATGY motif should also be explored via
mutagenesis. The Thr, Gly and Tyr residues that form the C-terminal end of the motif and
form the beginning of Lβ4β5 should be explored as they precede the dynamic loop
replacing helix α4 in Sma0114. Point mutations for each residue should be tested for the
ability to bind BeF3- and any changes in Sma0113 inhibition. Further NMR studies
including a 1H-15N HSQC and 15N relaxation should be performed to identify changes in
conformation and dynamics as a result of the mutations.
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Reprinted from Sheftic et al. (76)
I performed kinetic assays and electron microscopy (Figures A1-1, A1-2, A1-3)
Jessica Snell performed NMR experiments (Figure A1-4)
Dr. Suman Jha performed ITC experiments (FigureA1-5)

Appendix One. Misfolding of SEVI Inhibited by Physiological Metal
Ions
Abstract
SEVI (semen derived enhancer of viral infectivity), a naturally occurring peptide
fragment of prostatic acid phosphatase, enhances HIV infectivity by forming cationic
amyloid fibrils that aid the fusion of negatively charged virions and target cell
membranes. Cu(II) and Zn(II) inhibit fibrillization of SEVI in a kinetic assay employing
the fibril-specific dye Thioflavin T. Transmission electron microscopy (TEM) suggests
that the metals do not affect fibril morphology. NMR shows that the metals bind to
histidines 3 and 23 in the SEVI sequence. Isothermal titration calorimetry (ITC)
experiments indicate that SEVI forms oligomeric complexes with the metals.
Dissociation constants are micromolar for Cu(II) and millimolar for Zn(II). Because the
Cu(II) and Zn(II) concentrations that inhibit fibrillization are comparable to those found
in seminal fluid the metals may modulate SEVI fibrillization under physiological
conditions.
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Introduction
SEVI is a naturally occurring 39-residue (4.6 KDa) proteolytic fragment of human
prostatic acidic phosphatase (PAP248-286) that was discovered in a screen of semen
compounds for effects on HIV infectivity (77). The SEVI peptide is present at a
concentration of ~35 µg/ml in semen, and can assemble into amyloid fibrils with a cross
β-sheet structure at concentrations above 2 µg/ml (77). The fibrils attach to virions and
facilitate their fusion to target cells, thereby increasing HIV infectivity up to 400,000-fold
(77). As such, the SEVI peptide could be an important facilitator of HIV transmission.
The positively charged amyloid fibrils formed by SEVI are thought to promote
viral fusion by reducing electrostatic repulsion between negatively charged virus and
target cell membranes (77-79). The activity of SEVI appears to be general, in that it
promotes cell-fusion of a variety of HIV variants (77) as well as human XMRV, a
retrovirus that may play a role in prostate cancer (80). SEVI also boosts infectivity
nonspecifically for a number of other retroviruses - a finding that may have applications
to therapeutic gene transfer (81). The generality of the charge-screening mechanism is
further emphasized by the observation that designed peptides, with sequences unrelated
to SEVI, retain the ability to enhance HIV infectivity as long as they assemble into fibrils
with cationic surfaces (82).
Semen contains a very complex mixture of compounds (77, 83-85). It has been
shown recently that anionic buffer molecules in human seminal plasma accelerate
fibrillization (86), whereas other components such as proteases inhibit fibrillization by
degrading SEVI (84). In this work, we focus on how SEVI fibrillization is affected by
heavy metals since these are found at large concentrations in seminal plasma and have
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been shown to modulate the fibrillization of other amyloidogenic proteins and peptides
including Aβ (87), amylin (88, 89), α-synuclein (90), β-microglobulin (91), insulin (92),
and prion protein (93).
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Results
Cu2+ and Zn2+ Inhibit SEVI Fibrillization
Figure A1-1 shows the effects of increasing CuCl2 (Figure A1-1A) and ZnCl2
(Figure A1-1B) concentrations on SEVI fibrillization. Both metals inhibited fibrillization
compared to control samples of SEVI with a 5 mM concentration of the metal chelator
EDTA. Additional control experiments were used to establish that the presence of EDTA
had no effect on the fibrillization kinetics. The Zn2+ and Cu2+ ions are good ligands for
histidines (88), which are present at positions 3 and 23 in the SEVI amino acid sequence.
In addition to these metals, the effects of 1 mM Ca2+ and Mg2+ which are poor ligands for
histidine imidazole rings (88) were explored. Inhibition of fibrillization was observed
with 1 mM MgCl2 although to a lesser extent than with CuCl2 or ZnCl2. By contrast,
CaCl2 had negligible effects compared to the control samples without metals.
Nucleation of a fibrillization reaction is entropically disfavored due to the loss of
rotational and translational degrees of freedom when monomers aggregate. The lag phase
of the fibrillization curve represents the period of time before nucleation occurs. Once a
critical mass or nucleus forms, the reaction enters a growth phase in which addition of
monomers becomes enthalpically favorable as new non-covalent interactions form during
the fibril elongation process. The reaction ultimately reaches a steady state plateau
determined by the solubility of the monomers. The effects of Zn2+ and Cu2+ on the kinetic
parameters characterizing SEVI fibrillization reactions (lag times, elongation rates, and
plateaus) are shown in Figure A1-2. The most striking effect is seen on the lag times for
fibrillization (Figure A1-2A). These increase 4 to 8-fold in the presence of the metals
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compared to control samples containing SEVI alone, suggesting that the nucleation part
of the reaction is inhibited in the presence of metals.
The lag times show a constant 4-fold increase with Cu2+ concentrations in the
range between 0.001 – 0.1 mM, consistent with a low dissociation constant for Cu2+ (see
ITC section below). At the largest concentration of 1 mM CuCl2, there is a reversion to
shorter lag times but these nevertheless remain about 2-fold longer than for SEVI without
metals. Lag times also increase with increasing Zn2+ concentrations, reaching a plateau at
0.1-1.0 mM ZnCl2. The data are consistent with a Zn2+ dissociation constant in the range
of ~1 mM, a value some 3 orders of magnitude larger than that for Cu2+.
At the lowest 0.001 mM concentrations of Cu2+ and Zn2+ tested, there is a twofold reduction in fibril elongation rates compared to SEVI alone. This suggests that in
addition to interfering with nucleation the metals hinder the addition of SEVI monomers
to growing fibrils. As the metal concentration is increased up to 1 mM, however, the
elongation rates show no further decrease, within experimental uncertainty (Figure A12B). When the fibrillization reactions enter a steady state, the fluorescence plateaus show
a slight decrease with increasing Cu2+ concentrations, whereas they increase with
increasing Zn2+ concentrations (Figure A1-2C). Experiments done with a lower SEVI
peptide concentration of 1 mg/ml showed the same increase in lag times and decrease in
rates but the fluorescence plateaus were decreased for both Cu2+ and Zn2+. Fluorescence
plateaus often correlate with the amount of fibrils formed but can also be influenced by
differences in fibril morphology that affect interactions with the dye ThT.
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Figure A1-1 Inhibition of SEVI fibrillization with increasing concentrations of (A)
CuCl2 and (B) ZnCl2. All experiments were done with 2 mg/ml SEVI in PBS buffer, pH
7.4 at a temperature of 37°C. Error bars are the standard errors of the mean values
calculated from triplicate runs and are shown every tenth point for clarity.
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Figure A1-2 Semi-logarithmic plots showing the CuCl2 (black) and ZnCl2 (gray)
concentration dependence of kinetic parameters for SEVI fibrillization derived from the
data in Figure A1-1. (A) Lag times. (B) Fibril growth rates. (C) ThT fluorescence
plateaus. Uncertainty bars represent the standard errors from kinetic parameters of
experiments run in triplicate. The horizontal lines marked “control” are ranges for
parameters obtained from SEVI experiments without metals.
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Even if the larger fluorescence plateaus in the presence of 0.01-1.0 mM Zn2+ are due to
larger numbers of fibrils in the presence of large Zn2+ concentrations, the lag times under
these conditions are increased eight to nine fold (Figure A1-2A) so that Zn2+ would be a
potent inhibitor of fibrillization on physiological timescales.

Fibril Morphology is Retained but the Amount of Fibrils is Lowered in the Presence of
Zn2+ and Cu2+
Having established that Zn2+ and Cu2+ inhibit fibril formation, we next wanted to
see if the metals affected the morphologies of the fibrils. Figure A1-3 compares control
SEVI fibrils formed in the absence of metals (Figure A1-3A) to fibrils formed in the
presence of 1 mM ZnCl2 (Figure A1-3B) or CuCl2 (Figure A1-3C). High magnification
TEM images show that the metals have no apparent effects on fibril morphology (Figure
A1-3). Lower magnification images given in the insets for Figure A1-3 suggest that the
amount of SEVI fibrils is reduced in the presence of 1 mM ZnCl2 or CuCl2 compared to
the control.

NMR Mapping Identifies the Two Histidines in SEVI as the Ligands for Zn2+ and Cu2+
Previous NMR studies reported that the SEVI peptide is intrinsically unfolded at
37°C but folds into an α-helical structure in 50% trifluoroethanol similar to that of the
corresponding 248-286 segment in the parent protein human prostatic acid phosphatase
(94). The changes in the NMR spectrum accompanying binding of diamagnetic zinc to
SEVI are manifested as line-broadening, caused by intermediate exchange between the
free and bound forms of the peptide. To better characterize the binding site, 2D 1H-15N
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HSQC spectra of a 3 mM SEVI sample at natural isotopic abundance were acquired.
Spectra were recorded in the absence of metals, in the presence of a 2:1 peptide:Zn2+
ratio, and at a 1:1.3 peptide:Zn2+ ratio (Figure A1-4A). Losses in 1H-15N HSQC
crosspeak volumes due to intermediate exchange between the free and bound peptide are
localized to residues 2-6 and 23-24, flanking the two histidines at positions 3 and 23.
Line broadening is observed at substoichiometric concentrations of Zn2+, and
there are only small additional decreases of crosspeak volumes as the metal concentration
becomes saturating. The magnitude of the line broadening effects is similar for the
regions surrounding His3 and His23, suggesting the two histidines bind Zn2+
simultaneously (Figure A1-4B). Consistent results implicating His3 and His23 as the
ligands for Zn2+ were seen in 1H-13C HSQC spectra of SEVI, except that less residues
could be analyzed due to the poorer chemical shift dispersion in the carbon spectrum. We
obtained analogous results for the binding of paramagnetic Cu2+ to SEVI except that a
larger number of crosspeaks were broadened in the 1H-15N HSQC and 1H-13C HSQC
spectra. Although the sequence profiles are less well-defined than with Zn2+, the NMR
data show that His3 and His23 also serve as the ligands for Cu2+.

ITC Shows SEVI Forms Oligomeric Complexes with Cu2+ and Zn2+
ITC experiments were conducted to obtain information on the stoichiometry and
thermodynamics of metal binding (Figure A1-5). The titration for Cu2+ is well-defined
and indicates that the metal binds with a substoichiometric Cu2+/SEVI ratio of n = 0.3 and
a dissociation constant of 2 µM (Figure A1-5A).
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Figure A1-3 TEM images of SEVI fibrils. Images at 150,000x magnification. Control
experiment showing SEVI fibrils grown in the absence of metals (A), in the presence of 1
mM ZnCl2 (B), and in the presence of 1 mM CuCl2 (C). The insets for each panel show
images obtained at a lower magnification of 11,000x.
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Figure A1-4 Effects of ZnCl2 on the NMR spectrum of SEVI. (A) The three
superimposed natural 15N abundance 1H-15N HSQC spectra in the absence of zinc (black
contours), 1.5 mM ZnCl2 (green contours) and 4 mM ZnCl2 (red contours). NMR
assignments for SEVI in blue text indicate peaks that are unaffected and in purple text for
residues that experience NMR signal broadening in the presence of zinc. (B) Plot of
crosspeak volume loss (%) with ZnCl2, as a function of residue position in the SEVI
sequence.
87

The value of n = 0.3 suggest SEVI binds Cu2+ as a trimer, in which His3 and His23 from
three SEVI monomers constitute the ligands of an octahedral metal coordination site. ΔG
and ΔS values for the Cu2+ binding reaction were -32.5 ± 1.6 kJ/mol and 39.9 ± 5.4
J/(molK) respectively.
The ITC data indicates that SEVI binds Zn2+ three orders of magnitude weaker
than Cu2+. We obtained an apparent dissociation constant of 1.7 ± 0.9 mM, however, this
value is subject to considerable uncertainty due to weak affinity of SEVI for Zn2+. ΔG
and ΔS values for the Zn2+ binding reaction were -15.8 ± 8.4 kJ/mol and -163 ± 234
J/(molK) respectively. Similarly, the n-value obtained from ITC of 0.45 ± 0.40 indicates
substoichiometric binding but does not allow us to establish precisely how many SEVI
molecules are bound to a Zn2+ ion. Whereas Cu2+ prefers octahedral or planar
coordination in proteins (95), tetrahedral coordination is preferred for Zn2+ and octahedral
coordination is rare (96).
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Figure A1-5 ITC experiments. Cu2+ (A) and Zn2+ (B) binding to SEVI. Upper panels
show the heats evolved during the titrations. Lower panels show the enthalpy changes
with increasing metal:SEVI mole fraction. The data were fit to a single binding site
(independent binding) model.
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Discussion
These data show that Zn2+ and Cu2+ inhibit SEVI fibril formation (Figures A1-1,
A1-2) but do not affect fibril morphology (Figure A1-3). Inhibition is achieved by
coordinating the two histidines at positions 3 and 23 in the SEVI sequence (Figure A1-4).
Cu2+ is more effective in inhibiting SEVI fibrillization than Zn2+ and this correlates with
the tighter binding of the former metal ion to SEVI (Figure A1-5).
The normal concentrations of Cu2+ in human semen is 1-3 µM (83, 97),
comparable to the Kd of 2 µM determined for binding of the metal to SEVI by ITC
(Figure A1-5A). Zinc concentrations in seminal plasma are about 2.5 mM (0.16 g/L) (83,
85, 97), higher than in any other body fluids or tissues (83, 98). Although Zn2+ has a large
Kd of 2 mM (Figure A1-5B), the concentration of zinc in semen should be sufficiently
high to bind SEVI under physiological conditions. The inhibition of SEVI fibrillization
by metals could be relieved when the peptide is transferred to a different environment
following intercourse. It has been previously shown that the ability of SEVI to enhance
HIV infectivity is retained in the acidic environment of the vaginal tract (77). In the
vaginal tract, the concentrations of Cu2+ and Zn2+ are smaller than in semen (99, 100) and
the acidic pH of 4.2 (77) would reduce affinity for these metals due to protonation of the
histidine ligands.
Cu2+ and/or Zn2+ have been reported to inhibit the fibrillization of a number of
amyloidogenic peptides and proteins including amylin (88, 89), insulin (92), Aβ (101),
and prion protein (93). A common theme that emerges from these studies is that the
metals inhibit fibrillization by coordinating disordered segments of the polypeptide
chains and inducing oligomeric structures that are not competent for fibril assembly. For
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amyloidogenic precursors that exist as folded globular proteins, such as transthyretin, a
possible strategy to inhibit fibrillization is to develop molecules that bind and thereby
stabilize the native state (102). The present work, as well as previous work on the
inhibition of amyloidogenic proteins by metals (88, 89, 92, 93), suggests that compounds
that bind and stabilize non-native structures incompatible with fibril assembly may
provide an avenue for the development of inhibitors of amyloidogenic polypeptides that
are intrinsically unfolded.
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Materials and Methods
Preparation of SEVI Peptide
SEVI was purchased as a custom-synthesized peptide from Biopeptide (San
Diego, CA). The samples were 95% pure by HPLC and had a peptide content of 70%.
Samples were received as lyophilized powders and resuspended in 100% dimethyl
sulfoxide (DMSO) to make stock solutions of 100 mg/ml peptide. The stock solutions
were kept at -80°C when not in use. For experiments, SEVI stocks were diluted in the
desired buffers to a final concentration of 4% (v/v) DMSO. CuCl2, ZnCl2, MgCl2, and
CaCl2 were from Sigma. EDTA was from Fisher. All buffers were prepared with Milli-Q
water and filtered through a 0.22 µm Millipore filter before use. Buffers for monitoring
fibril formation were additionally treated with Chelex-100 to remove trace metals,
according to the manufacturer’s instructions (Bio-Rad, Hercules CA).

SEVI Fibril Formation Kinetics
Fibril kinetic assays were conducted in white 96-well clear-bottom Corning
Costar plates (Lowell, MA) sealed with clear polyester tape to prevent evaporation.
Unless otherwise specified, 200 µl samples were used with 2 mg/ml of SEVI in pH 7.4
PBS buffer (8 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl and 140 mM NaCl). The
SEVI concentration used for this work is lower than the 5-10 mg/ml typically used in
previous studies (77, 79, 103, 104). The peptide concentration was chosen as a
compromise between peptide cost and the time required to complete fibrillization, since
reproducibility worsens with increasing reaction times (105). We examined a series of
SEVI concentrations between 0.1 and 5 mg/ml and found that the ThT fluorescence
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plateaus for the fibrillization reactions scale nearly linearly, except at high peptide
concentrations where nonspecific aggregation may start to compete with fibrillization
(92).
The phosphate buffer used in this work poses the potential problem of
precipitating metals, as well as forming complexes which reduce the free metal ion
concentration (106, 107). The precipitating phosphate (PO43-) ion forms with a pKa of
12.6, so that at a physiological pH of 7.4 its concentration will be only 0.006% of the
total phosphate concentration, namely 0.6 µM for 10 mM phosphate buffer (106).
Consistently, we saw no visible precipitation of the samples even at the highest 1 mM
metal concentrations used in our PBS buffer. Because the metals can form soluble
complexes with H2PO4- and HPO42- ions, however, the effective free metal concentration
in solution may be as much as 10-fold lower than the total metal concentration (107). As
an alternative to phosphate, we conducted experiments in 20 mM Tris with 150 mM
NaCl (TBS) buffer at pH 7.4, and saw a dependence on CuCl2 concentration similar to
that observed in PBS. The amount of fibrils formed in TBS buffer for control samples
that had no metals, however, were about 7-fold lower than in PBS based on the ThT
fluorescence plateaus at the end of the reaction. The time for completion of the reactions
increased about 6-fold in TBS compared to PBS at the same SEVI peptide concentration.
Tris, like phosphate, can associate with divalent metals (106). In 20 mM HEPES with
150 mM NaCl pH 7.0, which is a Good buffer (108) that should have minimal
interactions with metals, we detected a 10-fold lower ThT fluorescence plateau and a 3fold increase in reaction times. These results are consistent with a recent report that SEVI
fibrillization is markedly enhanced in anionic buffers such as phosphate (86). We thus
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used PBS buffer for SEVI fibrillization studies because it consistently gave the best
results, and because this buffer most closely replicates physiological conditions (85).
In addition to SEVI peptide and buffer, each fibrillization reaction had a 15 µM
concentration of the amyloid-specific dye ThT to detect fibrils (109), a 0.02 % (v/v)
concentration of NaN3 to prevent bacterial growth during the fibrillization reactions, and
a Teflon bead which improves reproducibility by providing more efficient mixing of the
reaction components (105, 110). The plates were maintained at a temperature of 37°C
throughout the experiments. A continuous agitation speed of 240 rpm was used for the
reactions. While agitation is necessary for SEVI to form fibrils (77, 104) we found that
increasing the agitation speed from 240 to 1,200 rpm had no effects on fibril formation
kinetics. Fibrillization reactions were carried out in triplicate to obtain estimates on the
uncertainties of kinetic parameters. The fluorescence of ThT was measured every 30 min
on a Fluoroskan Ascent plate reader (Franklin, MA) using excitation at 440 nm and
emission at 490 nm (109). Lag times and rates for fibrillization reactions were obtained
from non-linear least-squares fits of the data to a published 6-parameter equation (111).
Reaction plateaus were determined from the fluorescence maxima when the reactions
first reached a steady-state. At longer times, once fibrils have formed, the solution is no
longer homogeneous so that the fluorescence values can become unreliable (112).

Transmission Electron Microscopy (TEM)
Samples for TEM were prepared from 1 mg/ml solutions of SEVI incubated with
continuous agitation for 15 days in PBS buffer at pH 7.4 and a temperature of 37°C. The
samples contained 1 mM concentrations of either ZnCl2 or CuCl2. We also looked at
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control samples without metals and 5 mM EDTA. ThT fluorescence was used to confirm
that all fibrillization reactions had reached the plateau stage prior to imaging by TEM.
Samples were applied to 400 mesh carbon coated copper grids and negatively stained
using 1% uranyl acetate. The samples were applied in 4 µl aliquots to the grids, rinsed
with 1 µl of H2O, and excess liquid was wicked from the grid using filter paper. To stain
the samples, 4 µl of 1% uranyl acetate was applied for 45 sec and the excess stain was
wicked off with filter paper. Electron micrographs were obtained using a FEI Tecnai G2
BioTWIN instrument, which is part of the UConn TEM facility.

NMR Spectroscopy for SEVI
NMR data were collected on a 600 MHz Varian Inova spectrometer equipped
with a cryogenic probe. The experiments were preformed on 3 mM samples of SEVI in
90% H2O/10% D2O. The pH was adjusted to 5.5 or 7.4 using aliquots of 1 M HCl and
NaOH solutions. The temperature for the experiments was 10°C to avoid loss of amide
proton signals through solvent exchange. NMR assignments were obtained using 2D
experiments from the Varian Protein Pack. Residue-type assignments were obtained from
70 ms mixing time TOCSY experiments and sequential assignments were made from 300
ms mixing time NOESY spectra. These were supplemented with 1H-15N HSQC and Cαselective 1H-13C HSQC spectra collected on samples at natural isotopic abundance to
obtain 13C and 15N assignments. The NMR samples under quiescent conditions were
stable at 10°C as monitored by 1D NMR spectra collected before and after 2D NMR
experiments. NMR assignments have been deposited in the BioMagResonBank (BMRB)
under accession numbers 17924 (SEVI) and 17925 (SEVI with 4 mM ZnCl2). To
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characterize line broadening in the presence of ZnCl2 and CuCl2, crosspeak volumes in
1

H-13C HSQC and 1H-15N HSQC spectra were measured with the “integrator” utility of

the iNMR software (Mestrelab Research).

Isothermal Titration Calorimetry (ITC) for SEVI
Experiments were done at 25°C on a Nano ITC low-volume calorimeter (TA
Instruments, New Castle, DE). Samples were prepared in 20 mM Tris buffer at pH 7.5
containing 150 mM NaCl (TBS buffer). For the Cu2+ experiment, the SEVI concentration
was 200 µM and the starting ligand concentration was 1 mM CuCl2. Due to weaker
binding, the experiment with Zn2+ necessitated a SEVI concentration of 400 µM and a
starting ligand concentration of 2 mM ZnCl2. Since Zn2+ has a low solubility at basic pH,
the 2 mM ZnCl2 solution in 20 mM TBS buffer was prepared by serial dilution, starting
from a 200 mM ZnCl2 stock solution prepared in de-ionized water. All solutions were
filtered through 0.2 µm filters and degassed under vacuum for 15 min. Control titration
experiments to obtain the heat of dilution were performed by titrating TBS solutions of 1
mM CuCl2 or 2 mM ZnCl2, into TBS buffer without protein. The control experiments
showed that contributions from enthalpy changes due to dilution were negligible (ΔH < 1.0 kJ/mol). ITC data were analyzed with NanoAnalyze software (v. 2.1.13).
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Reprinted in part from Sheftic et al. (113)

Appendix Two. Ionization Constants of Free and Micelle-Bound
Amyloid-β

Abstract
Amyloid- beta (Aβ) is thought to contribute to the pathology of Alzheimer's
disease and like many amyloid peptides may exert cytotoxic effects at cell membranes. It
is therefore important to study the properties of these proteins in membrane-like
environments. The membrane mimetics most amenable for high-resolution structural
studies are micelle monolayers because at least some of the micelles are sufficiently
small for NMR studies. An understanding of the contribution of electrostatic interactions
to the structural stability of Aβ in the micelle-bound and intrinsically unfolded native
states is critical in achieving a more complete understanding of its structure and
dynamics. Owing to the fact that the individual contributions of charged residues as well
as individual point charges are prominent forces governing intra- and intermolecular
interactions we characterized pKa values for ionizable residues in free and micelle-bound
Aβ using NMR.
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Introduction
Electrostatic forces play important roles in protein folding, stability and
association (114). Charged functional groups can also contribute to enzymatic activity
and conformational transitions (114-117). A better understanding of electrostatic forces
provides information on biological mechanisms ranging from structure formation to
molecular recognition, and could lead to improved potential energy functions for protein
structure prediction and design (118-123).
NMR spectroscopy is unique in that it can measure ionization constants (pKa
values) with site-specific resolution (124). The protonated and unprotonated states of
ionizable residues are almost always in fast exchange on the NMR timescale (125) so that
a population-weighted average of the charged and neutral species is observed. At high
pH, the population-averaged chemical shift is dominated by the unprotonated form. As
the pH is lowered, the resonance position of the titrating site gradually shifts towards the
chemical shift of the protonated form, eventually reaching an acidic chemical shift
plateau as the population of the protonated form dominates. The pH value at the midpoint of the sigmoidal titration curve is the pKa value for the site in question. The pKa
value is typically determined from a non-linear least-squares fit of the NMR chemical
shift vs pH data to the model specified by the Henderson-Hasselbalch equation (116,
124). Although the majority of ionization equilibria are in fast exchange on the NMR
timescale, there are some exceptions. Histidine resonances sometimes broaden at pH
values near their pKa consistent with intermediate exchange between the protonated and
unprotonated species (126). For the vast majority of cases, however, ionization equilibria
are in fast exchange on the NMR timescale.

98

Many of the proteins involved in amyloidogenic diseases such as amyloid-beta
(Aβ), amylin, and α-synuclein (αS) function as membrane-bound proteins, or may exert
their cytotoxic effects through membrane bound forms (127, 128). Characterizing the
properties of these proteins in membrane-like environments has become vital. To this end
we decided to determine the pKa values of Aβ-40 (the 40 residue Aβ peptide) in sodium
dodecyl sulfate (SDS) micelles. The structure of the peptide bound to SDS micelles is
known and other biophysical studies have been performed (129). The present study
describes the measurement of ionization constants in Aβ by NMR spectroscopy.
Inferences are obtained from these experiments into the roles of charges in stabilizing the
folded structure of the peptide.
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Results
pH Titration of Aβ-40 via NMR
A series of 1H-15N HSQC spectra recorded as a function of pH can provide a
straightforward and sensitive way to obtain titration data for charged amino acids (116,
130). Figure A2-1 illustrates 1H-15N HSQC spectra recorded during a pH titration of
monomeric Aβ-40 free in solution. NMR chemical shifts can be easily measured with
very high accuracy relative to an internal reference compound such as DSS or TSP (66).
From the pH series chemical shifts were derived for ionizable residues in Aβ-40. Figure
A2-2 shows representative titration curves for Glu11 in Aβ-40 where chemical shifts
were recorded as a function of pH.

Interpretation of pKa Values in Terms of Stability
The foundation for interpreting pKa data in terms of protein stability is the
thermodynamic linkage cycle shown in Figure A2-3, where F is the folded state, FH is
the protonated folded state, U is the unfolded state, and UH is the protonated unfolded
state (131). The vertical arrows describe the change in free energy on folding or
unfolding (∆GF or ∆GU). The horizontal arrows describe equilibria related to the
protonation of a residue in the folded (∆GFH) or unfolded state (∆GUH). The contribution
of a charge to protein stability, is therefore given by equation 1 (132, 133):

∆∆Gtitr = -2.303RT *(pKaU - pKaN)
(1)
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Figure A2-1 1H-15N HSQC spectra of Aβ-40. Each spectrum was recorded at a different
pH and chemical shifts were monitored for perturbations. Note that there are no spectra
shown for basic pH values (>8.0) where there is a loss of amide proton peaks because of
base-catalyzed exchange with the solvent. All spectra shown were recorded in the
absence of SDS micelles at a temperature of 20°C.
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Figure A2-2 Titration of Glu11 using observed chemical shifts as a function of pH. (A)
Chemical shifts recorded in the absence of SDS micelles for HN and N nuclei. (B)
Chemical shifts recorded in the presence of 100 mM SDS for HN and N nuclei.

102

where R is the gas constant, T is absolute temperature, pKa U is the pKa of a site in the
unfolded state (Table A2-1) and pKa N is the pKa of a site in the folded state (Table A2-1).
The pKa value of each ionizable site was used to estimate the free energy contribution
from protonation to the stability of the folded state using thermodynamic linkage, as
shown in Figure A2-3B (116, 131, 134).

Results with Micelle Bound Aβ-40
The pKa data for free Aβ-40 and for the peptide bound to SDS micelles are
summarized in Table A2-1. Similar data have been previously obtained for a 1-28 residue
fragment of Aβ (135). We wanted to see if residues 29-40 in the naturally occurring 40residue fragment Aβ-40 affected the pKa values. Our data for Aβ-40 are in very good
agreement with those previously reported for the 1-28 fragment. The two exceptions are
His6 and Glu11 in the SDS bound form of the peptide. For His6 we think the chemical
shift of the high pH form in the previous study (135) was probably misassigned to
formate, a common and almost ubiquitous impurity in NMR samples that resonates at
8.44 ppm. With our assignment of the high pH plateau of the Hε proton of His6 to 7.7
ppm, the pKa value for His6 becomes very close to those of the other two histidines. The
other small change is that we obtain a pKa of 6.14 for Glu11 from the pH-dependence of
its backbone amide proton chemical shift. In the previous report for the 1-28 fragment a
pKa of 5.5 was obtained from the γ-methylene resonances of Glu11 (135). Our correction
for Glu11 brings its pKa closer to those of other glutamates in Aβ-40 (Table A2-1).
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Figure A2-3 Shift in pKa values between folded and unfolded states and the calculation
of a change in folding free energy from a change in charge (∆∆Gtitr). (A) Titration data
illustrating the pKa shift for Lys8 between the folded and unfolded states of the GCN4p
coiled coil (116). In this case the positively charged state of Lys8 stabilizes the GCN4p
structure; the side-chain becomes protonated at a lower hydronium ion concentration in
the native state (pKa 11.3) compared to the unfolded state (pKa 10.6). (B) The
thermodynamic cycle that can be used to quantify the contribution of a change in charge
to a change in stability. U is the unprotonated unfolded state, UH is the protonated
unfolded state, F is the unprotonated folded state, FH is the protonated folded state, and R
is the gas constant. ∆∆Gtitr needs to be multiplied by -1 for acidic groups, and by the
number of magnetically equivalent monomers if used for an oligomeric protein. In the
present example, for Lys8 in the GCN4p coiled coil dimer ∆∆Gtitr = -1.9
(kcal/mol•dimer) at a temperature of 25oC.
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The pKa values for free and micelle bound Aβ-40 as well as the ∆∆Gtitr values are
summarized in Table A2-1. We see large and uniform pKa shifts when the protein is
bound to SDS corresponding to ∆∆G values of a magnitude between 1.2 and 2.7 kcal/mol
at 20°C. For groups that become positively charged when ionized, the contributions are
favorable likely reflecting attractive interactions with the sulfate headgroups of SDS.
For groups that become negatively charged on ionization the thermodynamic
contributions are unfavorable, most likely due to electrostatic repulsion with the
negatively charged sulfate headgroups of the micelles. Another system we looked at is
the unique histidine at position 50 of αS (Figure A2-4). It is worth noting that αS prefers
binding to membranes with a high proportion of negatively charged lipids so the
negatively charged SDS micelles in this case should be a better model than neutral DPC
micelles (136). We identified a large pKa shift from 6.33 for the free protein to 7.26 for
the protein bound to SDS micelles. The larger pKa in the presence of SDS indicates
His50 takes up a proton at smaller hydronium ion concentrations presumably because of
electrostatic attraction between the positively charged histidine and the negatively
charged sulfate groups on the SDS micelle.
The pKa shift in His50 of αS corresponds to an energetically favorable ∆∆Gtitr of 1.3 kcal/mol at 37°C. By contrast in neutral DPC micelles the pKa is raised only to 6.59,
corresponding to a ∆∆Gtitr of -0.4 kcal/mol. There appears to be a residual interaction,
possibly involving a weak ion pair between Glu46 and His50 but its contribution to the
stability of the folded structure is much smaller than that between His50 and the
negatively charged micelle sulfate groups of SDS. The pKa values for Aβ-28 bound to
DPC micelles have been reported previously (135) and for all 10 ionizable residues
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investigated large pKa shifts were observed when the peptide was bound to negatively
charged SDS micelles. By contrast, when bound to neutral DPC micelles the pKa values
for Aβ-28 were similar to those of the unstructured peptide in D2O (135).
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Table A2-1 Ionization constants for Aβ(1-40) and free energy contributions to the
stability of the SDS micelle-bound structure.
Residue

pKa free

pKa SDS

∆∆Gtitr

Resonance

H2O/D2Ob

(kcal/mol)
N-term

8.11 ± 0.64

7.99 ± 0.15

0.16 ± 0.88

Asp 1 (Hβ1,2)

D 2O

Asp 1

3.79 ± 0.40

5.43 ± 0.11

2.19 ± 0.56

Ala 2 (H)

H 2O

Glu 3

4.62 ± 0.34

6.17 ± 0.12

2.08 ± 0.48

Glu 3 (H)

H 2O

His 6

6.77 ± 0.03

7.87 ± 0.05

-1.47 ± 0.08

His 6 (Hε1)

D 2O

Asp 7

4.20 ± 0.12

5.55 ± 0.09

1.81 ± 0.20

Asp 7 (H/N)

H 2O

Tyr 10

11.42 ± 0.22

12.30 ± 0.05

1.18 ± 0.30

Tyr 10 (Hε1,2)

D 2O

Glu 11

4.40 ± 0.31

6.15 ± 0.13

2.34 ± 0.45

Glu 11 (H)

H 2O

His 13

6.67 ± 0.02

7.72 ± 0.07

-1.41 ± 0.10

His 13 (Hε1)

D 2O

His 14

6.65 ± 0.02

7.82 ± 0.05

-1.57 ± 0.07

His 14 (Hε1)

D 2O

Lys 16c

10.50 ± 0.24

> 12.5

< -2.5

Lys(Hε1,2-Hδ1,2)

D 2O

Glu 22

4.13 ± 0.07

6.12 ± 0.04

2.66 ± 0.11

Glu 22 (H)

H 2O

Asp 23

4.25 ± 0.10

5.52 ± 0.04

1.70 ± 0.14

Asp 23 (N/H)

H 2O

Lys 28c

10.5 ± 0.24

> 12.5

< -2.5

Lys(Hε1,2-Hδ1,2)

D 2O

C-term

3.72 ± 0.09

5.25 ± 0.02

2.41 ± 0.12

Ala 40 (H/N)

H 2O

All data were collected at a temperature of 20°C in the absence of added salts. For the
values of the peptide bound to SDS micelles, the SDS concentration was 100 mM.
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Figure A2-4 Titration curves of His50 from αS in various solvents. All data were
collected at 37°C. For the micelle samples the concentrations of SDS and DPC were 100
mM.
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Discussion
In summary, binding of proteins to SDS micelles appears to induce large shifts in
pKa values. For negatively charged amino acid sidechains the shifts indicate energetically
unfavorable interactions due to electrostatic repulsion. For positively charged amino acid
sidechains the pKa shifts indicate energetically favorable interactions between opposite
charges. The magnitudes of the shifts appear to be similar in the different systems we
looked at (Aβ and αS), and while they show some dependence on residue type (Table A21) they show little dependence on the location of the ionizable group in the amino acid
sequence or in the 3-dimensional structure. The pKa shifts of the glutamate residues
investigated are uniformly larger than those of the histidines (Table A2-1). The location
of glutamate residues in the sequence, however, did not affect pKa shifts observed
suggesting that the perturbations seen were independent of sequence position. This is
important, because residues 1-14 are unstructured in micelle bound Aβ, while residues
15-36 fold into an α-helical structure with a kink between residues 25-27 (129).
Moreover, paramagnetic relaxation enhancement spin-label experiments show that the
segments 15-24 and 29-35 reside on the surface and in the interior of the micelle,
respectively; while the unstructured segments 1-14 and 36-40 are solvent exposed. The
pKa shifts for Aβ are insensitive to the differences in structural properties and to the
positioning of the different parts of the polypeptide with respect to the micelle (137).
Taken together these observations suggest that SDS micelles act as polyanions
and provide an electrostatic screen for the entire peptide, that appears to be independent
of structure and the degree of immersion of the polypeptides into the micelle. In other
words, this screening appears to be non-specific with respect to structural context. In the

109

case of DPC micelles we expected that if ion pairs within Aβ provided large stabilizing
forces we would see large pKa shifts between the free and bound forms. However, the
results with DPC micelles show that pKa values are similar for bound and free protein
(135) where the neutral character of these micelles would not provide electrostatic
screening. This strongly suggests that electrostatic interactions within the protein are
small, compared to those between the protein and the charged micelles.
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Materials and Methods
Aβ-40 Preparation for NMR
Natural abundance Aβ-40 was from EZBiolab (Camel, IN) and 15N labeled Aβ-40
was purchased from rPeptide (Bogart, GA). NMR data were collected at a temperature of
20°C on a 600 MHz Varian Inova instrument equipped with a cryogenic probe in the
absence of added salts. For experiments with micelles, the SDS concentration was 100
mM. For experiments in H2O, data were obtained by following the indicated backbone
amide resonances using 1H-15N HSQC experiments. At high pH the experiments no
longer work because of rapid amide proton exchange. For experiments in D2O we
followed resonances either using 1D 1H NMR for the aromatic residues, or 2D TOCSY
for the aliphatic protons. For experiments with micelles we used natural abundance SDS
in H2O and d25-SDS in D2O.

pKa Measurements by NMR
To precisely define a pKa value, a titration series of about 10 – 15 spectra are
collected at different pH points. For more demanding experiments it may be possible to
obtain a pKa value with a greater experimental uncertainty from about 6-8 pH points.
The most important parts of the titration curve to define are the midpoint, and the acidic
and basic plateaus. When planning an experiment it is therefore important to sample pH
points near the pKa and to define the acidic and basic plateaus, by collecting one or two
pH points far from the pKa.
Because of sample losses from pipetting and pH measurements a larger sample
volume larger than necessary, 0.7 mL for a standard 5 mm NMR tube, was used. The pH
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adjustments were made using stock solutions of acid and base, typically at 1 M
concentrations. The acid and base solutions were delivered using 0.2 to 2.0 µl aliquots.
For titrations in D2O, it was necessary to use DCl and NaOD to avoid introducing H2O
into the sample. The pH electrode was also rinsed in 99.8% D2O before pH
measurements, to avoid introducing H2O. The deuterium isotope effect on the pKa is
about 0.4 pH units. It is known, however, that it is approximately equal and opposite in
sign to the deuterium isotope effect on glass electrodes so that no correction was needed
for titrations in D2O compared to H2O (124).
Electrode 2- and 3-point calibrations against pH 4, 7, and 10 buffers were
performed for accurate results. The pH of the sample was measured both before and after
collecting an NMR spectrum, and the average between these two values was used as the
experimental pH. Typically the difference between the pH measured before and after the
NMR experiment was within 0.1 to 0.2 pH units. There are two different types of pH
electrodes available. Glass electrodes have the advantage of having extensive literature
on corrections for the effects of isotopes on the pH measurements and for the effects of
denaturants such as urea (116, 124, 138, 139). Metal electrodes have the disadvantage
that the effects of isotopes or denaturants on pH measurements are not as well
characterized as for glass electrodes. Glass electrodes have a particular disadvantage
when working with SDS detergent micelles. The potassium salt of SDS is highly
insoluble, so even a trace amount of KCl from the storage solution of a glass electrode
invariably leads to precipitation of some of the micelles. To avoid any precipitation
metal electrodes were used exclusively when studying Aβ-40 in the presence of
detergents or lipids.
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Analysis of pKa Values
The data from the pH titration series were analyzed using a non-linear leastsquares fit to the Henderson-Hasselbalch equation 2 (124, 140):

(2)

where pKa is the ionization constant, δlow is the low pH chemical shift plateau, δhigh is the
high pH chemical shift plateau, and n is the apparent Hill coefficient. With these four
parameters it is possible to reconstruct the chemical shift of a titrating nucleus at any pH.
The Hill coefficient parameter in principle should describe the cooperativity of the
titration (124). Values of n less than 1 suggest negative cooperativity. Values of n greater
than 1 suggest positive cooperativity (124, 141).
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Appendix Three. Visualizing Amyloid-β Complexes

Abstract
The amyloid-beta (Aβ) peptide is linked to the onset and progression of
Alzheimer's disease. Two isoforms of the peptide are present in cerebrospinal fluid (Aβ40 and Aβ-42). The two peptides differ by two C-terminal residues due to variances in
sequential proteolysis reactions of the amyloid precursor protein (APP). Despite their
strong sequence homology the two peptides have markedly different behavior in vitro and
in vivo. Aβ-42 forms the cross β-sheet amyloid fibril structures at a much faster rate than
Aβ-40 whereas Aβ-40 is found in 10-fold higher concentrations in vivo. Interestingly, the
two peptides also co-localize in amyloid deposits in vivo. In order to explore the possible
association of the two peptides into a single amyloid fibril total internal reflection
fluorescence (TIRF) microscopy was used. The preliminary work here shows that
monomeric Aβ-42 forms fibrils that are shorter when grown in the presence of
monomeric Aβ-40. It is unclear whether the two peptides co-localize into a single
structure but this data shows that Aβ-40 affects the fibrillization of Aβ-42 by possibly
acting to inhibit the addition of monomeric Aβ-42 to the growing ends of fibrils once the
reaction is in the fibril elongation phase.
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Introduction
Proteins can fold into a native conformation as well as misfold into a non-native
state. Often proteins can form new misfolded structures that impart detrimental functions.
A well-studied class of such proteins is the amyloid family. Amyloids are protein
aggregates that have a cross β-sheet structure in which each β-strand is stacked
perpendicular to the fibril axis (142, 143). Proteinacious aggregates are believed to
disrupt normal cellular activity and are often a pathological hallmark of a variety of
diseases (144, 145) including Parkinson's Disease, Prion disease and Alzheimer's Disease
(146).
Although it is unclear how these proteins transform into fibrils of ordered β-sheet
structure, amyloid fibril formation follows nucleation kinetics (147, 148). The kinetics of
the reaction can be monitored using ThioflavinT (ThT) assays that can be used to
determine variables including reaction rates and lag times (Figure A3-1). ThT is an
exogenous fluorescent dye that binds specifically to the cross-beta sheet structure unique
to amyloid fibrils (149).
The amyloid beta (Aβ) peptide is a byproduct of the sequential proteolytic
cleavage of the transmembrane amyloid precursor protein (APP). Two isoforms, the 40mer and 42-mer, are the most common products of APP cleavage (150, 151).
Cerebrospinal serum Aβ-42 is detected at about 10-fold lower levels than Aβ-40 but can
accelerate the aggregation of Aβ-40 (152). It has been shown that altering the ratio of the
two peptides by increasing the amount of Aβ-42 relative to Aβ-40 causes a decrease in
the lag phase for Aβ-40 fibrillization (153). More specifically, when the ratio of Aβ-40:
Aβ-42 is 7:3 the toxicity of the fibrils formed is increased (152). The amount of Aβ-42
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present in cerebrospinal fluid is strongly correlated with Alzheimer’s disease. The
increase in Aβ-42 relative to Aβ-40 in familial mutants leads to an early onset of the
disease (152). The ratio of Aβ-42 relative to Aβ-40 is also used as a diagnostic tool for
separating Alzheimer's disease from non-Alzheimer's disease related dementia (154,
155).
Amyloid fibrils formed by the association of a single protein can have a variety of
morphologies, posing the possibility that multiple reaction pathways for aggregation are
possible (156). It is possible that the two Aβ peptides can be incorporated into a single
growing fibril due to their strong sequence similarity. Furthermore, Aβ fibrils formed by
the incorporation of both peptides may have different morphologies wherein an increase
of Aβ-42 relative to Aβ-40 may prompt the reaction to favor fibrils of a different
morphology. The hetero or homogeneity of a fibril during growth can be imaged using
total internal reflection fluorescence (TIRF) microscopy (157, 158). Determining if both
peptides are incorporated into a single fibril may shed light on why changes in the ratio
between Aβ-40 and Aβ-42 leads to changes in the rate of fibril formation (150).
Complimentary studies by TEM can provide information on the morphology of the fibrils
formed in the presence of both peptides.
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Figure A3-1 Representative amyloid fibrillization reaction monitored by ThT
fluorescence. The reaction is characterized by three phases: the lag phase in which the
protein remains monomeric until a critical nucleus is formed, the growth phase in which
the energetic losses in rotational and translational entropy are compensated by enthalpic
increases due to the addition of monomeric protein to a protofibril structure and the
plateau phase in which an apparent steady-state between growing fibrils and free
monomers is reached.

117

Results
Microscopy of Aβ-40 and Aβ-42 Peptides
Control experiments were used to generate kinetic reaction curves using ThT
assays of the peptides conjugated to fluorescent dyes (Figure A3-2). The Aβ-40 peptide
was conjugated to HyLyte Fluor 488 (Aβ-40-488) and Aβ-42 was conjugated to HyLyte
Fluor 555 (Aβ-42-555). The sigmoidal transition for Aβ-40-488 (Figure A3-2A) appears
inverted when compared to the curve generated from a ThT assay in the absence of other
fluorescent dyes (Figure A3-1). The reaction inversion is likely due to Förster resonance
energy transfer (FRET) between the ThT and attached HyLyte fluor dye wherein ThT
excitation is absorbed by the conjugated 488 dye. A similar inverted profile is seen for
Aβ-42-555 (Figure A3-2B) albeit the absence of a detectable lag phase. Due to fast
aggregation of Aβ-42 it is likely that the lag time between the preparation of the peptide
and the first ThT measurement was longer than the lag time for fibrillization. To confirm
the presence of fibrils from reactions using Aβ-40-488 and Aβ-42-555 transmission
electron microscopy (TEM) images were collected (Figure A3-3). The conjugated dyes
do not appear to affect fibril formation or morphology. For comparison, Aβ-40 fibrils
formed without conjugated dyes and in the absence of the exogenous ThT dye are shown
in Figure A3-4.
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Figure A3-2 ThT kinetic assays for Aβ-40-488 (A) and Aβ-42-555 (B). Blue curves
represent 20 µM and 10 µM peptide concentrations in (A) and (B) respectively. Pink
curves represent 40 µM and 20 µM peptide concentrations in (A) and (B) respectively.
Green curves represent 80 µM and 40 µM peptide concentrations in (A) and (B)
respectively.
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Figure A3-3 TEM images of Aβ-40-488 (A) and Aβ-42-555 (B). All images were
collected at 49,000X magnification. Samples were negatively stained with 1% uranyl
acetate on 400 mesh carbon-coated copper grids.
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Figure A3-4 TEM images of Aβ-40 fibrils at 11,000X magnification. Fibrils in the inset
were imaged at 49,000X magnification. Monomeric Aβ-40 was incubated in 20 mM
Na2HPO4 pH 7.4 for 14 days prior to imaging. Fibrils were negatively stained with 1%
uranyl acetate on 400 mesh carbon-coated copper grids.
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TIRF microscopy on Aβ-42-555 shows long extended fibrils similar to those seen
in TEM images. TIRF on Aβ-40-488 shows more diffuse fibrils that are difficult to image
above the baseline noise (Figure A3-5) and when both peptides are in a reaction mixture
it is very difficult to see Aβ-40-488 signal. Due to the diffuse nature of Aβ-40-488 fibrils
we used an excess of Aβ-42-555 relative to Aβ-40-488 to obtain better images. The
peptide ratio of 2:1 Aβ-42-555:Aβ-40-488 has been successfully imaged using TIRF. In
the images in Figure A3-6 it is clear that the length of the Aβ-42-555 fibrils in the 2:1
Aβ-42-555:Aβ-40-488 reaction are shorter when compared to the Aβ-42-555 fibrils
prepared alone.
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Figure A3-5 TIRF microscopy of Aβ-40-488 fibrils formed in the absence of Aβ-42555. A monomeric concentration of 40 µM Aβ-40-488 was used to generate the fibrils.
Fibrils were formed in a solution containing 20 mM Na2HPO4 with 50 mM NaCl and
0.02% NaN3.
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Figure A3-6 TIRF microscopy of Aβ-42-555. (A) 20 µM Aβ-42-555. (B) 20 µM Aβ-42555 with 10 µM Aβ-40-488. Both solutions contain 20 mM Na2HPO4 with 50 mM NaCl
and 0.02% NaN3.
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Discussion
It is unclear at this point whether or not Aβ-40 and Aβ-42 co-localize into a
heterogenous fibril. The diffuse fluorescence of Aβ-40-488 by TIRF could be the product
of a lesser amount of fibrils formed in the reaction with this isoform. TEM of the Aβ-40488 peptide suggests that lower quantities of fibrils are formed when compared to the
Aβ-42-555 peptide reaction (Figure A3-4). It is likely that the lack of fibrils formed by
Aβ-40-488 translates into an inability for the fibril structures present to produce enough
fluorescence to overcome background fluorescence in the samples used for TIRF. The
enhanced quantity of fibrils formed from Aβ-42-555 visualized by TEM (Figure A3-4)
translates into increased signal via TIRF (Figure A3-6).
TIRF of Aβ-42-555 suggests that at least the length of fibrils formed by Aβ-42 are
shortened upon addition of Aβ-40. This is consistent with previous work that suggests
that the addition of Aβ-40 monomers to Aβ-42 monomers increases the lag time for
fibrillization (159) and decreases toxicity (160). As such the data presented here supports
a reaction where nucleation and fibril elongation are affected by the interaction of the two
isoforms. The shortened fibrils formed could lessen the density of fibrillar deposits in
vivo, which could lead to decreased cellular damage particularly at the membrane surface
thus decreasing toxicity.
In future studies the diffuse nature of the Aβ-40-488 fibrils should be explored
further. The 488 dye itself may be responsible for the diffuse fluorescence seen from
TIRF microscopy. One way to test the dye is to switch the 488 and 555 dyes on the Aβ40 and Aβ-42 peptides, that is to say Aβ-40 should be conjugated to the 555 dye and Aβ42 should be conjugated to the 488 dye. TIRF microscopy would then reveal if the

125

diffuse fluorescence is a property of the 488 dye or the Aβ-40 peptide. Furthermore, TEM
images of the mixed peptide reactions should be collected to confirm the TIRF finding
that Aβ-42 fibril lengths are decreased when they are formed in the presence of
monomeric Aβ-40. These studies will lay a foundation for studying the impact of several
different ratios of Aβ-40 and Aβ-42 on fibril heterogeneity and morphology.
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Materials and Methods
Fluorescently Tagged Aβ Preparation
Samples were prepared from 0.1 mg HyLyte Fluor Aβ-40-488 and 0.1 mg HyLyte
Fluor Aβ-42-555 purchased from Anaspec (San Jose, CA). HyLyte Fluor Aβ-40-488 was
dissolved in 1% NH4OH per the manufacturers instructions to a final concentration of
435 uM. Likewise, HyLyte Fluor Aβ-42-555 was dissolved in 1% NH4OH to a final
concentration of 385 uM. The peptide solutions were then sonicated in a cold water bath
at 70% amplitude for 5 minutes. Stock solutions were immediately diluted to
concentrations of 10-80 µM in white 96-well clear-bottom Corning Costar plates (Lowell,
MA) sealed with clear polyester tape to prevent evaporation. Stock solutions were always
made fresh on the day of use. Fibrillization reactions were carried out in 20 mM
Na2HPO4 buffer at pH 7.4 with 50 mM NaCl and 0.02% NaN3. All solutions were filtered
with 25 µm syringe filters. Fibrillization reactions were allowed to progress at room
temperature for 20 days before TIRF imaging. For ThT experiments, ThT was added to a
final concentration of 15 µM. ThT was purchased from Anaspec.

Aβ Kinetics and TEM
ThT fluorescence assays conducted at 25°C were used to confirm that fibrils were
formed from the tagged peptides. The kinetic profiles were inverted from typical reaction
curves. Assuming fluorescent interference, namely FRET, was responsible, TEM images
were taken of the peptides to confirm fibril formation. Samples were applied to 400 mesh
carbon coated copper grids and negatively stained using 1% uranyl acetate. The samples
were applied in 4 µl aliquots to the grids, rinsed with 1 µl of H2O, and excess liquid was
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wicked from the grid using filter paper. To stain the samples, 3 µl of 1% uranyl acetate
was applied for 45 seconds and the excess stain was wicked off with filter paper. Electron
micrographs were obtained using a FEI Tecnai G2 BioTWIN instrument.

TIRF Chamber Preparation
In order to perform TIRF microscopy, solutions need to be contained in a very
thin area or "chamber" created between two different glass surfaces with different
refractive indices. In order to create these chambers a glass coverslip (Fisher Cat. No. 12542-C; Pittsburg, PA) was sealed to a glass slide (Fisher Cat. No. 12-544-I; Pittsburg,
PA) leaving a very thing space between the two surfaces. In order to create the chamber
space clear sealant was applied to the slide and the coverslip was then placed ontop of the
sealant as it dried. The thin space formed between the coverslip and slide was able to
hold up to 50 uL of solution. Prior to sealing, the glass surfaces both were cleaned using
1% w/v Alconox detergent and then subsequently rinsed with deionized water. Both
surfaces were cleansed with 70% v/v ethanol and allowed to air dry immediately before
sealant was applied.

TIRF Microscopy
Samples were prepared as described above albeit no ThT was used for TIRF
experiments. Fibril containing samples were injected in 30-40 uL aliquots to chambers
created as described above. Slides were inverted for imaging on an Andor Revolution XD
Spinning Disk Confocal instrument with a Nikon TiE inverted microscope. Excitation
filters of 488 and 560 nm were used to image Aβ-40-488 and Aβ-42-555 respectively.
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Images were recorded with an Andor 897 iXon EMCCD camera using an oil immersion
TIRF lens (1.49 NA, 100X, Nikon) at a temperature of 25°C.
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